Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value
3035880	pf-ph	— (—)	710	795	100.00%
3035880	pf-ph	__________ (ph)	39	47	0.00%
3035880	pf-ph	pH (ph)	20	29	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other pulmonary diagnosis

417

117

17.98

316.83

1.3

1.1

7.40

7.48

5.09

282

COPD differential diagnosis

414

115

18.17

315.64

1.3

1.1

7.40

7.48

5.10

282

ILD differential diagnosis

414

115

18.16

315.61

1.3

1.1

7.40

7.48

5.10

282

Excluding asthma or asthma-COPD overlap

415

117

17.90

314.80

1.3

1.1

7.40

7.48

5.11

284

Heart failure,strict

605

662

6.49

313.75

1.3

1.2

7.43

7.37

6.92

425

466

COPD (mode)

274

22.37

313.23

1.3

1.1

7.39

7.48

4.49

202

Pneumonia, organism unspecified

839

848

6.86

307.65

1.3

7.40

7.41

0.21

579

604

Pneumonias (Asthma/COPD co-morbidities)

887

872

6.72

307.65

1.3

7.41

0.08

602

616

Any death

689

791

6.20

307.65

1.3

7.40

0.09

506

524

762

719

6.26

307.65

1.3

7.41

0.02

523

514

Pleural effusion

1055

194

63.49

307.65

1.4

1.1

7.39

7.41

0.41

798

116

All pneumoniae

885

870

6.68

307.65

1.3

7.41

0.09

599

617

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

888

884

6.76

307.65

1.3

7.41

0.08

604

626

Lung cancer and mesothelioma

405

53.40

307.65

1.3

1.1

7.39

7.47

2.57

304

Other medical care

624

876

6.09

307.65

1.3

1.2

7.41

7.40

0.12

470

596

Pyothorax

282

33.74

307.65

1.4

7.22

7.43

11.15

176

Suppurative and necrotic conditions of lower respiratory tract

310

122

29.17

307.65

1.4

1.3

7.24

7.43

11.28

198

Influenza and pneumonia

855

849

6.27

307.65

1.3

7.40

7.41

0.07

582

604

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

762

719

6.26

307.65

1.3

7.41

0.02

523

514

Other diseases of pleura

1429

488

26.99

307.65

1.4

1.1

7.40

7.41

0.45

1081

301

Other pleural conditions

613

123

57.33

307.65

1.5

1.2

7.39

7.45

2.38

488

Heart failure, not strict

672

802

5.70

304.58

1.3

1.2

7.43

7.38

5.53

463

561

Asthma, unspecified (mode), excluding more controls

243

37.24

299.85

1.3

1.0

7.39

7.46

1.56

170

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

429

435

8.37

295.38

1.3

7.39

7.42

1.20

322

297

Heart failure, strict

671

918

5.17

278.42

1.3

1.2

7.43

7.38

6.90

474

648

Malignant neoplasm of respiratory system and intrathoracic organs

389

403

8.27

266.25

1.3

7.38

7.41

1.69

295

274

All-cause Heart Failure

649

906

5.07

263.87

1.4

1.2

7.43

7.37

6.73

462

642

Asthma, unspecified (mode)

255

113

16.39

244.57

1.3

1.1

7.39

7.48

4.41

181

Asthma, excluding more controls

273

29.97

243.17

1.3

1.0

7.41

7.46

1.07

183

Bacterial pneumoniae

426

593

6.40

242.19

1.3

7.40

0.01

286

420

Asthma (only as main-diagnosis), excluding more controls

251

29.67

237.48

1.2

1.0

7.41

7.46

0.90

164

Bacterial pneumonia, not elsewhere classified

411

568

6.45

235.37

1.3

7.41

0.11

274

404

Later onset COPD, excluding more controls

205

20.41

222.81

1.3

1.1

7.39

7.48

3.45

149

Other bacterial diseases

711

1173

4.05

219.34

1.3

1.2

7.41

7.40

0.26

484

830

Bacterial infection, other or unspecified, including avohilmo

563

1028

4.54

216.02

1.4

1.3

7.40

0.03

405

727

Malignant neoplasm of bronchus and lung, including Hilmo

343

403

7.30

213.04

1.2

1.3

7.39

7.42

1.06

250

273

Bacterial infection, other or unspecified

538

1006

4.57

210.02

1.4

1.3

7.40

0.03

385

712

Asthma

289

115

13.02

198.02

1.3

1.1

7.41

7.48

3.20

196

Asthma (only as main-diagnosis)

268

115

13.09

194.81

1.3

1.1

7.41

7.48

3.25

179

Dyspnoea

687

1357

3.68

192.64

1.3

7.41

7.40

0.84

508

934

Diseases of the respiratory system

303

138

11.07

188.25

1.4

1.1

7.40

7.46

3.42

211

Non-small cell lung cancer, including Hilmo

265

320

8.02

187.68

1.2

1.3

7.39

7.42

1.25

196

220

Malignant neoplasm of bronchus and lung

303

367

7.10

183.99

1.2

1.3

7.38

7.42

1.54

223

248

Other bacterial diseases, including avohilmo

665

1106

3.78

183.71

1.3

1.2

7.41

7.40

0.27

447

783

Asthma (mode)

268

115

12.30

181.19

1.3

1.1

7.41

7.48

3.13

182

Heart failure and antihypertensive medication

275

201

9.05

177.94

1.4

1.2

7.43

7.36

2.52

196

133

Bacterial Sepsis

501

986

4.26

177.85

1.3

7.42

7.39

1.55

350

700

Explicit Sepsis, including avohilmo

455

952

4.39

173.15

1.3

7.40

7.39

0.42

319

677

Septicaemia

438

899

4.50

172.37

1.3

7.41

7.40

0.28

308

639

Explicit Sepsis

447

944

4.37

169.40

1.3

7.41

7.39

0.52

313

672

Implicit bacterial Sepsis

455

925

4.28

164.43

1.3

7.42

7.39

1.94

325

660

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

572

1434

3.51

157.93

1.4

1.3

7.39

7.41

1.56

413

1007

Renal failure

516

1181

3.78

157.19

1.4

1.3

7.43

7.39

3.53

371

841

Other septicaemia, including avohilmo

403

866

4.43

156.83

1.3

7.41

7.40

0.36

291

618

Early onset COPD, excluding more controls

120

19.55

154.60

1.3

1.1

7.39

7.44

0.80

Bacterial pneumonia (organism specified)

451

1024

4.04

154.00

1.3

7.40

0.06

308

731

Oxycodone

418

840

4.31

152.66

1.3

7.40

0.10

309

596

Other septicaemia

395

859

4.40

152.54

1.3

7.41

7.40

0.40

285

614

Implicit bacterial Sepsis, including avohilmo

464

977

4.00

152.32

1.3

7.42

7.39

1.65

332

693

Non-ischemic cardiomyopathy

342

528

5.23

151.90

1.3

1.2

7.43

7.37

3.54

234

368

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

239

361

6.78

150.63

1.2

1.3

7.39

7.43

1.20

184

241

Abnormal findings on diagnostic imaging of lung

486

1252

3.73

150.06

1.3

7.37

7.41

1.80

353

882

Persons encountering health services for specific procedures and health care

628

1080

3.45

150.04

1.3

1.2

7.40

0.08

452

725

Non-invasive ventilation

204

209

8.53

147.64

1.3

1.2

7.44

7.38

1.85

172

136

Renal tubulo-interstitial diseases

601

1325

3.35

147.36

1.3

7.42

7.40

2.22

432

919

All chronic kidney diseases

490

1062

3.72

143.70

1.4

1.3

7.43

7.39

2.85

368

737

Non-small cell lung cancer

191

238

8.20

141.03

1.2

1.3

7.37

7.43

2.20

141

160

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

644

1395

3.13

138.60

1.3

7.41

7.40

0.48

457

981

Heart failure and bmi 25plus

334

435

5.20

137.62

1.3

7.43

7.36

3.57

240

315

Non-small cell lung cancer, adenocarcinoma

132

107

12.92

135.04

1.2

1.3

7.36

7.44

2.54

Heart failure and coronary heart disease

455

882

3.67

125.02

1.4

1.3

7.43

7.38

4.60

327

625

Implicit Sepsis

525

1194

3.26

124.04

1.3

7.42

7.40

1.54

386

839

COPD/asthma related infections

510

719

3.57

120.19

1.3

7.40

7.41

0.09

351

514

COPD/asthma/ILD related infections

510

719

3.57

120.19

1.3

7.40

7.41

0.09

351

514

Anaemias

118

23.09

117.74

1.3

7.42

7.32

1.20

Respiratory insufficiency

25.75

116.07

1.4

1.2

7.43

0.04

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

24.14

114.87

1.5

1.3

7.36

7.41

0.75

Chronic kidney disease

362

936

3.78

114.53

1.4

1.3

7.43

7.40

2.07

269

665

Other heart diseases, wide

437

728

3.65

114.36

1.3

1.2

7.43

7.37

6.55

293

500

Other heart diseases

217

209

6.79

114.11

1.3

1.2

7.43

7.36

2.54

144

138

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

242

465

5.13

113.49

1.3

7.42

7.41

0.23

186

318

Malignant neoplasm

454

755

3.54

112.49

1.3

7.40

0.07

320

511

Malignant neoplasm

451

754

3.52

110.91

1.3

7.40

0.09

317

510

Malignant neoplasm of heart, mediastinum and pleura

30.00

110.30

1.6

1.3

7.36

7.38

0.20

Fever of other and unknown origin

398

996

3.49

109.43

1.3

7.40

0.09

288

708

Non-allergic asthma (mode), excluding more controls

33.24

108.69

1.3

1.0

7.45

7.44

—

All kidney diseases

560

1301

2.90

105.94

1.3

7.43

7.40

3.33

401

899

Malignant neoplasm, including Hilmo

443

752

3.45

105.54

1.3

7.41

7.40

0.07

302

510

Implicit Sepsis, including avohilmo

507

1204

3.03

105.22

1.3

7.43

7.40

2.02

370

844

Liquid cancers, including Hilmo

285

593

4.28

104.68

1.4

1.3

7.42

7.40

0.70

219

411

Mesothelioma

33.62

104.26

1.6

1.3

7.37

0.01

Malignant neoplasm, wide definition

442

757

3.42

103.86

1.3

7.41

7.40

0.05

304

513

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

109

11.41

103.51

1.4

1.3

7.39

7.45

1.72

Mesothelioma, including Hilmo

27.95

103.10

1.6

1.4

7.36

7.37

0.14

Other diseases of pericardium

15.77

102.12

1.4

1.1

7.44

7.36

1.84

Solid cancers

432

746

3.41

101.64

1.3

7.40

7.41

0.21

303

507

Abnormalities of breathing

488

891

3.15

100.73

1.3

1.2

7.41

7.40

0.50

357

594

Any event in cancer register

449

806

3.27

98.97

1.3

7.40

7.41

0.27

310

546

Dialysis, with operation codes

163

258

6.48

98.41

1.4

1.3

7.42

7.40

0.37

125

181

Malignant neoplasm of mesothelium and soft tissue

15.25

97.81

1.5

1.4

7.40

7.42

0.42

Atrial fibrillation and flutter with reimbursement

174

151

7.34

95.73

1.3

1.2

7.45

7.35

3.70

117

100

Solid cancers, including Hilmo

425

754

3.30

95.02

1.3

7.40

0.05

294

510

Atrial fibrillation and flutter

181

177

6.65

93.22

1.4

1.2

7.45

7.36

3.59

125

118

Valvular heart disease excluding rheumatic fever

302

552

3.94

92.90

1.4

1.2

7.44

7.35

8.65

220

379

Any gastric operation

324

396

4.12

91.96

1.3

7.41

7.40

0.13

223

254

GASTRO-related operations

324

396

4.12

91.96

1.3

7.41

7.40

0.13

223

254

Non-rheumatic valve diseases

300

550

3.92

91.81

1.4

1.2

7.44

7.35

8.58

220

377

Pneumothorax

13.34

91.50

1.4

1.2

7.40

7.41

0.13

Acute renal failure

245

594

4.20

90.66

1.4

1.3

7.43

7.40

1.25

177

418

Condition for Implicit Sepsis (Organ dysfunction codes)

484

1192

2.83

88.62

1.3

7.43

7.40

2.12

347

838

Non-small cell lung cancer, adenocarcinoma, helper endpoint

132

188

7.33

88.45

1.2

1.4

7.36

7.40

0.89

128

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

479

1151

2.82

86.81

1.3

7.42

7.40

1.28

338

812

Erysipelas, including avohilmo

429

1084

2.95

86.27

1.3

1.2

7.41

7.40

0.04

286

770

Diseases of arteries, arterioles and capillaries (FINNGEN)

149

144

7.21

84.75

1.4

1.2

7.43

7.35

2.96

112

Nephropathy related operations

154

270

5.85

83.88

1.5

1.3

7.43

7.39

1.03

117

190

Undetermined asthma, excluding more controls

44.82

82.50

1.4

1.1

7.37

7.42

—

First line medication for Crohn's disease

559

1156

2.61

81.95

1.3

1.2

7.40

0.04

401

799

Cardiomyopathy

151

278

5.51

77.79

1.2

7.42

7.36

1.69

100

198

Non-allergic asthma (mode)

14.24

76.66

1.3

1.2

7.45

7.47

0.37

Ascites

119

180

6.82

75.25

1.2

1.3

7.41

0.00

119

Liquid cancers

220

535

3.93

73.90

1.4

1.3

7.42

7.41

0.40

167

367

Aplastic and other anaemias

381

1277

2.75

71.26

1.3

7.40

7.41

0.24

274

909

Oral corticosteroids

564

1387

2.39

71.23

1.3

1.2

7.41

7.40

0.21

404

976

Care involving dialysis

101

136

7.62

70.90

1.5

1.2

7.42

0.01

Erysipelas

352

1066

2.87

70.07

1.3

7.41

7.40

0.42

238

753

COPD

366

1064

2.82

69.50

1.3

7.39

7.40

0.21

262

747

Pleural plaque

130

7.62

68.30

1.2

1.1

7.36

7.43

1.19

Allergic asthma (mode), excluding more controls

26.10

68.13

1.3

1.1

7.44

7.43

—

Cardiac arrhythmias

237

402

3.79

67.15

1.4

1.2

7.44

7.38

3.60

165

268

Other disorders of fluid, electrolyte and acid-base balance

266

787

3.22

65.93

1.3

7.42

7.40

0.73

206

542

Other and unspecified anaemias

352

1224

2.72

64.88

1.3

7.39

7.41

0.37

250

868

Other anaemias

353

1228

2.71

64.59

1.4

1.3

7.39

7.41

0.40

251

871

Implicit viral Sepsis, including avohilmo

232

686

3.41

64.11

1.3

7.43

7.40

1.24

163

491

Other chronic obstructive pulmonary disease

346

1049

2.72

61.79

1.3

7.39

7.40

0.09

250

734

Provisional assignment of new diseases of uncertain etiology

341

1272

2.68

61.64

1.3

7.41

7.40

0.13

244

898

Codes for special purposes

341

1272

2.68

61.63

1.3

7.41

7.40

0.13

244

898

All influenza

158

370

4.31

61.16

1.3

7.42

7.40

0.80

116

256

Other diseases of the respiratory system

209

600

3.54

60.90

1.4

1.3

7.41

0.09

166

405

Other respiratory disorders and diseases

209

600

3.54

60.90

1.4

1.3

7.41

0.09

166

405

Viral pneumonia

103

168

6.22

60.33

1.4

1.2

7.43

7.41

0.39

113

Undetermined asthma

16.99

59.07

1.4

1.2

7.37

7.45

0.74

Hypertensive heart and/or renal disease

221

463

3.52

58.78

1.3

1.2

7.43

7.36

4.01

156

304

Cerebrovascular diseases (FINNGEN)

134

180

5.25

57.66

1.4

1.2

7.41

7.37

1.12

120

Covid-19 confirmed case

286

1021

2.82

57.31

1.3

7.40

0.03

206

709

COPD, hospital admissions

353

1184

2.53

55.04

1.3

7.39

0.05

256

829

Diseases of arteries, arterioles and capillaries

436

1389

2.32

54.34

1.3

7.41

7.40

0.64

301

989

Inflammatory bowel disease treatment related agents

542

1390

2.17

54.13

1.3

1.2

7.41

7.40

0.24

383

976

ILD medications: prednisolone, methylprednisolone, prednisone

519

1311

2.21

54.06

1.3

1.2

7.41

7.40

0.35

368

917

Other chronic obstructive pulmonary disease, including avohilmo

384

1314

2.42

53.97

1.3

7.39

7.40

0.20

279

921

Secondary uncertain malignant neoplasm

121

255

4.82

53.64

1.3

7.42

7.43

0.46

168

COPD, early/later onset

352

1195

2.49

53.07

1.3

7.39

0.04

255

836

COPD, hospital admission 2, with asthma infections

284

897

2.75

52.48

1.3

7.39

7.40

0.30

205

625

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

125

276

4.59

52.34

1.4

1.3

7.42

0.07

183

COPD, hospital admissions 3, with asthma pneumonia sepsis

262

791

2.87

52.20

1.3

7.39

7.40

0.55

191

550

Cardiomyopathy (excluding other)

106

205

5.25

51.92

1.2

7.40

7.38

0.34

144

Abscess of lung

15.46

51.56

1.2

1.1

7.33

7.43

1.18

Cardiovascular diseases (excluding rheumatic etc)

164

222

4.24

51.28

1.3

1.2

7.40

7.36

0.65

113

146

Asthma-related pneumonia

269

993

2.72

50.41

1.2

1.3

7.40

7.41

0.21

185

705

Valvular operations

114

241

4.79

50.33

1.4

1.2

7.42

7.36

2.30

169

Asthma, hospital admissions 3, pneumonia

269

995

2.72

50.21

1.2

1.3

7.40

7.41

0.21

185

705

Asthma-related pneumonia or sepsis

269

995

2.72

50.21

1.2

1.3

7.40

7.41

0.21

185

705

Haemorrhage from respiratory passages

235

714

2.93

49.36

1.3

7.42

7.39

1.53

184

477

Cardiomyopathies, Primary/intrinsic

101

196

5.23

49.30

1.2

7.41

7.38

0.64

137

ILD medications

517

1313

2.13

48.96

1.4

1.2

7.41

7.40

0.52

365

918

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

141

200

4.46

48.72

1.4

1.2

7.40

7.37

0.70

133

Acute tubulo-interstitial nephritis

335

1168

2.43

48.27

1.3

7.40

7.39

0.24

243

825

Implicit viral Sepsis

161

456

3.57

47.93

1.4

1.3

7.45

7.40

2.80

123

326

Viral Sepsis

161

456

3.57

47.93

1.4

1.3

7.45

7.40

2.80

123

326

COPD related to multimorbidity

316

1083

2.49

47.57

1.3

7.39

7.40

0.11

236

749

Other arrhythmias

253

674

2.81

47.33

1.3

1.2

7.42

7.37

2.97

190

464

Allergic asthma (mode)

12.05

47.27

1.3

1.2

7.44

7.45

0.12

Hypertensive diseases (excluding secondary)

150

209

4.19

46.62

1.3

1.2

7.42

7.36

1.47

100

138

Glomerular disorders in diseases classified elsewhere

119

279

4.34

46.31

1.4

1.3

7.39

0.00

198

Complications of surgical and medical care, not elsewhere classified

496

1617

2.05

45.25

1.4

1.3

7.43

7.40

2.19

356

1131

Pulmonary heart disease, diseases of pulmonary circulation

244

914

2.69

44.86

1.3

7.41

0.02

173

642

Glomerular diseases

152

434

3.55

44.79

1.4

1.3

7.40

0.05

107

299

Certain infectious and parasitic diseases

395

856

2.32

44.78

1.3

1.2

7.42

7.40

1.57

267

598

Hypertensive Heart Disease

187

441

3.25

44.63

1.3

1.2

7.43

7.36

3.44

126

290

Venous thromboembolism

345

1463

2.28

44.31

1.3

7.40

7.41

0.09

246

1041

Conduction disorders

175

425

3.32

44.11

1.4

1.2

7.43

7.35

6.21

135

302

Extracorporeal dialysis

142

5.79

43.24

1.6

1.4

7.43

7.39

0.50

Metabolic disorders

440

1243

2.13

43.07

1.3

7.42

7.40

0.93

319

860

AV-block

133

298

3.85

42.36

1.4

1.2

7.44

7.36

4.74

104

209

ILD, hospital admissions 3, with pneumonia sepsis

156

5.42

42.07

1.3

1.2

7.38

7.41

0.53

104

Pulmonary embolism

222

820

2.73

41.99

1.2

1.3

7.40

7.41

0.09

155

574

Pulmonary heart disease

222

824

2.72

41.61

1.2

1.3

7.40

7.41

0.16

155

576

ILD, hospital admission 2, with pulmonary infections

176

5.08

41.58

1.3

1.2

7.37

7.41

0.65

116

DVT of lower extremities and pulmonary embolism

284

1184

2.41

41.32

1.3

7.40

0.00

200

845

Secondary hypertension

8.64

40.61

1.3

1.1

7.45

7.36

1.70

Presence of cardiac and vascular implants and grafts

321

1023

2.32

40.52

1.4

1.3

7.44

7.40

3.37

233

713

Neoplasms

251

481

2.74

40.48

1.3

1.2

7.40

0.06

177

327

Polyarthropathies

362

1046

2.23

40.40

1.3

1.2

7.41

7.40

0.31

258

732

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

437

1338

2.07

40.31

1.3

7.42

7.40

1.30

309

924

Iron deficiency anaemia

276

1131

2.41

40.23

1.3

7.43

7.40

0.98

199

802

Dialysis

8.87

39.77

1.3

1.4

7.45

7.38

1.52

Diabetic nephropathy, excluding more controls

128

277

3.82

39.58

1.3

1.2

7.41

7.40

0.28

202

General symptoms and signs

440

1059

2.09

39.03

1.3

7.40

0.05

303

745

Type 2 diabetes, wide definition

402

1214

2.10

38.30

1.3

7.42

7.41

0.81

281

846

Other CVD (FINNGEN)

6.07

38.14

1.3

1.2

7.44

7.34

1.83

ILD medications: immunosuppressive drugs

283

1104

2.33

37.83

1.3

1.2

7.40

0.13

196

762

Percutaneous Coronary Intervention

379

1080

2.14

37.82

1.3

1.2

7.44

7.39

3.50

271

752

Chronic lower respiratory diseases

521

1428

1.93

37.73

1.3

7.40

7.41

0.30

361

1000

L01XE Protein kinase inhibitors

122

5.82

37.50

1.3

1.4

7.42

7.40

0.29

Insulin medication

337

1292

2.17

37.45

1.4

1.3

7.40

0.11

239

905

Hard cardiovascular diseases

374

1033

2.15

37.26

1.3

1.2

7.42

7.39

2.44

262

712

Malaise and fatigue

278

930

2.36

37.22

1.3

7.41

7.40

0.27

199

665

Bleeding

431

1517

2.00

37.13

1.3

7.42

7.40

0.92

316

1060

Nutritional anaemias

311

1347

2.21

37.09

1.3

7.43

7.40

1.68

227

960

Care involving use of rehabilitation procedures

270

1033

2.36

37.08

1.3

1.2

7.41

7.40

0.26

206

698

Peripheral artery disease

317

1131

2.23

36.97

1.3

7.42

7.39

0.98

219

817

Symptoms and signs involving the circulatory and respiratory systems

383

892

2.16

36.93

1.3

1.2

7.42

7.40

1.17

277

594

Pacemaker

284

1157

2.30

36.83

1.4

1.3

7.44

7.40

2.67

214

814

Hypertension, essential

294

700

2.38

36.78

1.3

1.2

7.42

7.38

1.81

202

470

Any reimbursement code in KELA

130

162

4.03

36.36

1.4

1.2

7.38

7.35

0.56

Hypo-osmolality and hyponatraemia

138

421

3.29

36.19

1.3

1.2

7.41

0.01

110

279

Paroxysmal tachycardia

146

4.86

36.16

1.4

1.2

7.44

7.34

3.25

102

Malignant neoplasm of ovary, including Hilmo

8.65

36.16

1.2

1.1

7.37

7.50

3.18

Complications of medical and surgical care

375

1657

2.04

35.98

1.4

1.3

7.43

7.40

2.00

278

1159

Ischemic heart diseases

381

1089

2.09

35.59

1.3

1.2

7.43

7.39

2.98

271

757

Complications of procedures, not elsewhere classified

396

1595

2.01

35.53

1.3

7.43

7.40

1.99

286

1118

Hypertensive diseases

292

705

2.34

35.28

1.3

1.2

7.41

7.38

1.59

201

472

Coronary revascularization (ANGIO or CABG)

371

1080

2.09

35.01

1.3

1.2

7.43

7.39

3.16

264

752

malignant neoplasm of female genital organs, including Hilmo

191

4.43

34.98

1.2

7.40

7.45

1.30

128

Hypertension

291

705

2.33

34.89

1.3

1.2

7.41

7.38

1.59

201

472

Atherosclerosis, excluding cerebral and coronary sclerosis

305

1091

2.21

34.88

1.3

7.41

7.39

0.67

213

788

Opioids

385

956

2.08

34.47

1.3

7.40

0.06

260

670

Asthma-related infections

305

1383

2.16

34.45

1.2

1.3

7.40

7.41

0.21

210

984

Asthma, hospital admission 2, infections

305

1383

2.16

34.45

1.2

1.3

7.40

7.41

0.21

210

984

Infections, IBD-co-morbidities

164

4.28

34.01

1.5

1.2

7.43

7.40

0.53

111

Malignant neoplasm of digestive organs, including Hilmo

217

630

2.55

33.51

1.2

1.3

7.41

7.40

0.19

156

435

Cardiovascular diseases

132

192

3.66

33.46

1.3

1.2

7.39

7.38

0.17

126

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

12.59

33.39

1.2

1.1

7.36

7.49

3.37

Emergency coronary revascularization (for ACS)

414

1274

1.97

33.09

1.3

1.2

7.43

7.39

2.82

299

889

Malignant neoplasm of breast, HER2-negative

134

256

3.39

32.79

1.2

1.1

7.46

0.01

169

Malignant neoplasm of breast

134

256

3.39

32.77

1.2

1.1

7.46

0.01

169

Secondary and unspecified malignant neoplasm of lymph nodes

127

5.27

32.64

1.5

1.3

7.42

7.45

0.54

Pericarditis

9.72

32.48

1.4

1.1

7.46

7.41

0.89

Major coronary heart disease event

391

1176

2.00

32.41

1.4

1.2

7.43

7.39

3.05

278

824

Primary_lymphoid and hematopoietic malignant neoplasms

177

668

2.68

32.28

1.4

1.3

7.41

0.22

138

462

L04AD Calcineurin inhibitors

154

4.73

31.49

1.3

1.4

7.41

7.40

0.20

114

Other and unspecified iron deficiency

211

877

2.42

31.25

1.3

7.43

7.41

0.49

149

612

Tramadol

328

944

2.09

31.03

1.3

7.41

7.40

0.46

217

665

Insulin, combination of fast acting with intermediate-acting or long-acting

338

1543

1.99

30.58

1.4

1.3

7.40

0.15

239

1093

Non-Hodgkin lymphoma, all, including Hilmo

248

3.79

30.46

1.4

1.3

7.42

7.43

0.29

170

Malignant neoplasm of breast, HER2-negative, including Hilmo

131

257

3.28

30.45

1.2

1.1

7.46

0.02

170

Malignant neoplasm of breast, including Hilmo

131

257

3.28

30.44

1.2

1.1

7.46

0.02

170

Continuous positive airway pressure

184

4.06

30.41

1.2

7.35

7.36

0.09

124

Transplanted organ and tissue status

175

4.40

30.36

1.4

1.3

7.42

7.40

0.51

120

Serous carcinoma of ovary, including Hilmo

11.29

30.31

1.2

1.1

7.36

7.50

2.98

Malignant neoplasm of digestive organs

199

610

2.51

30.17

1.2

1.3

7.41

0.15

141

424

Insulin, intermediate and long-acting

305

1441

2.05

30.14

1.3

7.41

7.40

0.23

216

1024

Hyperkalaemia

154

4.64

29.70

1.2

1.3

7.41

7.42

0.19

103

Explicit bacterial Sepsis, including avohilmo

230

3.87

29.67

1.3

7.39

0.06

163

Explicit bacterial Sepsis

226

3.90

29.59

1.3

7.39

0.06

161

Autoimmune diseases excluding thyroid diseases, strict definition

442

1292

1.87

29.53

1.3

7.40

0.15

309

904

STROKE

235

684

2.32

29.28

1.3

1.2

7.42

7.39

1.08

171

462

Adjustment and management of implanted device

134

461

2.94

29.17

1.4

1.3

7.40

7.41

0.23

308

Gout

214

787

2.35

28.92

1.3

7.42

7.39

1.11

156

553

malignant neoplasm of female genital organs

177

4.23

28.85

1.2

1.1

7.40

7.46

1.39

117

Unspecified kidney failure

288

3.49

28.57

1.2

1.3

7.45

7.40

1.83

202

Non-small cell lung cancer, squamous

5.62

28.54

1.4

1.3

7.39

7.42

0.33

Autoimmune diseases excluding thyroid diseases

453

1346

1.83

28.45

1.3

7.40

0.08

316

944

Major coronary heart disease event excluding revascularizations

319

1041

2.03

28.45

1.4

1.3

7.43

7.39

2.56

235

725

Later onset COPD

236

849

2.25

28.40

1.3

7.39

7.41

0.39

176

585

Hypothyroidism, drug reimbursement

11.46

28.39

1.2

1.3

7.42

7.29

1.21

Malignant neoplasm of breast, HER-positive

110

243

3.39

28.21

1.3

1.1

7.45

7.46

0.12

160

Malignant neoplasm of breast, ER-positive, including Hilmo

110

243

3.38

28.15

1.3

1.1

7.45

7.46

0.12

160

Malignant neoplasm of ovary

8.51

27.92

1.1

7.36

7.51

3.95

Insulin, fast-acting

197

861

2.30

26.21

1.4

1.3

7.40

0.14

142

600

Coronary atherosclerosis

316

1009

1.98

26.19

1.3

7.43

7.39

2.90

238

700

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

146

3.97

25.71

1.3

1.2

7.39

7.41

0.30

101

Pain in throat and chest

300

886

2.01

25.46

1.3

1.2

7.40

0.19

220

592

Gout, FINNGEN

214

975

2.20

25.41

1.3

7.42

7.39

1.15

156

696

Parasetamol

258

605

2.16

25.30

1.4

1.3

7.39

7.40

0.20

186

402

Other dialysis

6.92

25.17

1.3

7.46

7.38

1.68

Codeine

339

953

1.93

25.02

1.3

7.41

7.40

0.14

227

669

Streptococcal septicaemia

203

3.80

24.94

1.3

1.2

7.38

7.39

0.10

146

Depression medications

7.08

24.92

1.5

1.3

7.30

0.04

Streptococcal septicaemia, including avohilmo

208

3.75

24.86

1.3

1.2

7.38

7.39

0.10

148

Cardiodefibrillation

237

1141

2.09

24.68

1.4

1.3

7.43

7.39

2.42

166

807

Cardiomyopathy, other and unspecified

108

4.97

24.62

1.3

7.38

7.37

0.04

COPD-related respiratory insufficiency

106

358

3.00

24.00

1.3

7.41

0.03

242

Myocardial infarction

261

904

2.03

23.57

1.3

7.43

7.38

2.77

190

626

Hernia of abdominal wall, postoperative

219

3.56

23.44

1.3

7.44

7.39

0.82

137

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

7.18

23.41

1.6

1.4

7.43

7.42

0.14

Chronic lymphocytic leukaemia

7.18

23.41

1.6

1.4

7.43

7.42

0.14

Chronic lymphocytic leukaemia, helper endpoint

7.18

23.41

1.6

1.4

7.43

7.42

0.14

Certain infectious and parasitic diseases, including avohilmo

273

671

2.04

23.26

1.4

1.3

7.42

7.39

1.46

182

479

Oedema, not elsewhere classified

173

735

2.31

23.26

1.3

7.39

7.40

0.24

111

535

Diabetic nephropathy

130

492

2.64

23.14

1.3

7.41

7.40

0.36

357

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

383

1275

1.79

22.94

1.3

7.42

7.40

0.84

267

892

COPD, hospital admissions 1, only main diagnosis

238

1010

2.04

22.74

1.3

7.38

7.40

0.45

179

694

Amputation

298

3.13

22.41

1.4

1.3

7.39

7.40

0.18

216

Insulin, fast-acting or short human

197

921

2.15

22.32

1.4

1.3

7.40

0.16

142

642

Type 1 diabetes, wide definition, subgroup 1

320

3.01

22.14

1.3

7.41

7.39

0.33

218

Diabetes mellitus

392

1291

1.76

22.12

1.3

7.41

0.40

265

901

Nonischemic cardiomyopathy

225

3.46

22.12

1.3

1.2

7.41

7.40

0.01

149

Hypothyroidism (congenital or acquired)

6.86

21.88

1.2

1.3

7.41

7.32

0.86

Peripheral arterial reconstruction

142

586

2.45

21.73

1.3

7.42

7.40

0.46

413

Malignant neoplasm of skin, including Hilmo

210

660

2.14

21.69

1.3

7.42

7.41

0.59

145

455

Diabetes, varying definitions

389

1292

1.75

21.65

1.3

7.41

0.41

263

902

Asthma/COPD (KELA code 203)

373

1426

1.75

21.51

1.3

7.40

7.41

0.15

265

999

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

288

1527

1.86

21.50

1.4

1.3

7.43

7.40

2.11

217

1063

Type 1 diabetes

117

442

2.66

21.37

1.2

1.3

7.40

7.39

0.13

300

Kidney transplant status

5.48

21.22

1.4

1.3

7.45

7.39

1.27

Calcific aortic valvular stenosis

217

1032

2.04

21.19

1.4

1.3

7.44

7.41

1.66

166

722

Calcific aortic valvular stenosis, operated

217

1032

2.04

21.19

1.4

1.3

7.44

7.41

1.66

166

722

Malignant neoplasm of skin

205

652

2.14

21.17

1.3

7.41

0.16

141

451

Diabetes, insulin treatment (Kela reimbursement)

419

1473

1.70

21.06

1.3

7.42

7.40

1.14

293

1028

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

201

636

2.14

20.87

1.3

7.42

7.41

0.39

136

440

Misadventures to patients during surgical and medical care

316

2.97

20.85

1.6

1.3

7.44

7.40

1.55

212

Calcific aortic valvular stenosis, diagnosis (helper)

216

1032

2.03

20.83

1.4

1.3

7.44

7.41

1.66

166

722

Operations 2 for CAVS

216

1032

2.03

20.83

1.4

1.3

7.44

7.41

1.66

166

722

Infections of the skin and subcutaneous tissue

247

1267

1.92

20.67

1.3

7.40

0.08

173

886

Dipeptidyl peptidase 4 (DPP-4) inhibitors

302

1301

1.83

20.67

1.3

7.40

0.05

217

912

Hypothyroidism, levothyroxine purchases

6.74

20.63

1.2

1.3

7.40

7.32

0.79

Hypothyroidism and >3 levothyroxin purchases

6.74

20.63

1.2

1.3

7.40

7.32

0.79

Calcific aortic valvular stenosis, including rheumatic fever

216

1036

2.02

20.55

1.4

1.3

7.44

7.41

1.67

166

724

Type 2 diabetes

383

1285

1.73

20.51

1.3

7.42

7.40

0.52

260

899

Ulcer of lower limb, not elsewhere classified

113

430

2.66

20.50

1.4

1.3

7.37

7.41

0.57

296

Endocarditis

6.79

20.45

1.7

1.1

7.39

7.36

0.29

Implicit fungal Sepsis, including avohilmo

139

4.08

20.41

1.5

1.4

7.44

7.38

1.55

Hyperlipidaemia, other/unspecified

218

979

2.01

20.36

1.3

7.41

7.39

0.43

163

684

Caries of dentine

130

512

2.46

20.16

1.3

7.41

7.40

0.17

351

Other acute lower respiratory infections

257

1302

1.89

20.15

1.3

7.41

7.40

0.47

187

921

Diseases of oesophagus, stomach and duodenum

432

1538

1.66

20.11

1.3

7.42

7.40

0.54

298

1092

Type 1 diabetes, wide definition

100

360

2.79

20.10

1.3

7.42

7.39

0.34

248

Other diseases of blood and blood-forming organs, wide

127

518

2.47

19.94

1.3

7.38

7.40

0.47

352

Other disorders of skin and subcutaneous tissue

340

1658

1.74

19.88

1.4

1.3

7.41

7.40

0.11

240

1176

Osteopathies and chondropathies

256

1250

1.88

19.68

1.3

7.41

0.24

182

884

Disorders of lipoprotein metabolism and other lipidaemias

348

1212

1.75

19.66

1.3

7.42

7.40

1.35

247

842

Other bacterial intestinal infections

114

448

2.56

19.38

1.4

1.3

7.41

0.04

301

Pneumonia due to Streptococcus pneumoniae

6.76

19.15

1.3

1.4

7.32

7.40

0.55

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

106

405

2.64

19.12

1.4

1.3

7.37

7.40

0.55

281

Endocrine, nutritional and metabolic diseases

255

665

1.94

19.02

1.4

1.2

7.39

7.40

0.10

177

447

Fungal Sepsis

4.86

18.99

1.5

1.3

7.45

7.37

1.76

Implicit fungal Sepsis

5.04

18.82

1.5

1.3

7.45

7.37

1.74

Diseases of liver

174

831

2.10

18.79

1.4

1.3

7.38

7.41

0.67

118

577

Peripheral artery operations in Hilmo

366

2.70

18.48

1.3

7.38

7.40

0.22

262

Ischaemic heart disease, wide definition

337

1203

1.73

18.35

1.3

7.43

7.39

2.26

252

836

Unspecified acute lower respiratory infection

346

2.74

18.23

1.2

1.3

7.44

7.40

1.06

243

Fibrosis and cirrhosis of liver

189

3.43

18.21

1.4

1.3

7.41

7.40

0.12

132

Amputation of toe

209

3.31

18.18

1.3

1.4

7.38

7.39

0.13

148

Asthma (diagnoses ohter than nonallergic)

359

1740

1.67

18.16

1.3

7.40

7.41

0.03

248

1239

Myocardial infarction, strict

236

880

1.91

18.12

1.3

7.43

7.38

2.43

172

612

Disorders resulting from impaired renal tubular function

4.98

18.10

1.2

1.4

7.41

7.40

0.16

Volume depletion

235

3.14

18.04

1.4

1.2

7.43

7.42

0.14

151

Dental caries

137

568

2.29

18.01

1.3

7.41

7.40

0.11

395

Iron deficiency anaemia secondary to blood loss (chronic)

102

394

2.61

18.00

1.4

1.3

7.44

7.41

0.95

268

Other malignant neoplasms of skin (=non-melanoma skin cancer)

189

624

2.06

17.97

1.3

7.41

0.14

129

431

Other respiratory diseases principally affecting the interstitium

130

563

2.33

17.94

1.4

1.3

7.38

7.41

0.71

385

Enterocolitis due to Clostridium difficile

279

2.93

17.81

1.4

1.3

7.43

7.42

0.19

188

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

171

2.91

17.76

1.3

7.38

7.40

0.21

117

Malignant neoplasm, without specification of site, including Hilmo

4.94

17.56

1.1

1.2

7.41

7.45

0.41

Dilated cardiomyopathy

333

2.73

17.35

1.2

1.3

7.40

0.01

234

L04AA Selective immunosuppressants

104

413

2.53

17.34

1.3

7.42

7.40

0.33

276

Cough

161

716

2.10

17.27

1.3

1.2

7.40

0.05

118

483

Used for control exclusion in common control thyroid runs

401

1235

1.64

17.25

1.4

1.3

7.41

7.40

0.23

283

864

443

1408

1.60

17.18

1.3

7.40

0.01

315

1003

Coronary artery bypass grafting

167

594

2.10

16.89

1.3

7.42

7.39

1.34

114

420

Bacterial intestinal infections, IBD co-morbidities

111

461

2.43

16.84

1.4

1.3

7.41

0.05

309

All influenza (not pneumonia)

164

3.49

16.83

1.2

1.3

7.41

7.39

0.31

115

Angina pectoris

260

957

1.81

16.79

1.4

1.3

7.42

7.39

2.08

194

666

Abnormal findings on examination of blood, without diagnosis

255

1297

1.79

16.73

1.2

1.3

7.40

7.39

0.19

184

905

268

1364

1.76

16.71

1.2

1.3

7.37

7.39

0.42

180

961

Cirrhosis of liver, NAS

142

3.73

16.69

1.5

1.4

7.41

7.40

0.10

101

Basal cell carcinoma, including Hilmo

186

629

2.01

16.52

1.2

1.3

7.41

0.13

125

435

Substance abuse, excluding more controls

249

1161

1.80

16.50

1.2

1.3

7.37

7.40

0.89

163

820

Diseases of the digestive system

242

1341

1.80

16.49

1.4

1.3

7.42

7.40

0.46

171

947

Antihypertensive medication - note that there are other indications

124

265

2.45

16.45

1.3

1.2

7.40

7.36

0.96

179

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

404

1602

1.60

16.43

1.3

7.39

7.40

0.33

289

1125

Other retinal disorders

325

1481

1.67

16.40

1.3

7.42

7.40

1.00

238

1053

Intestinal infectious diseases

377

1743

1.61

16.39

1.3

7.42

7.40

1.20

274

1220

Basal cell carcinoma

181

613

2.02

16.35

1.3

7.41

0.02

123

423

Fall on same level

418

1404

1.59

16.12

1.3

7.41

0.01

265

1011

Syncope and collapse

205

907

1.89

16.02

1.3

7.41

7.40

0.22

149

646

Heart failure and hypertrophic cardiomyopathy

6.04

15.83

1.2

7.43

7.34

0.75

Bronchitis

432

1664

1.56

15.77

1.3

7.40

0.02

312

1171

Non-Hodgkin lymphoma, all

4.58

15.67

1.4

1.3

7.38

7.44

0.54

Acute peritonitis

149

3.54

15.55

1.3

1.4

7.42

7.39

0.38

110

Early onset COPD

120

536

2.25

15.45

1.3

7.39

0.01

363

Gout, idiopatic and unspecified

169

861

1.98

15.43

1.4

1.3

7.42

7.39

0.67

118

603

Enlarged lymph nodes

280

2.77

15.34

1.4

1.3

7.44

7.40

1.16

196

Stroke, including SAH

319

1388

1.65

15.33

1.3

7.42

7.40

0.85

235

966

Emphysema

190

3.20

15.32

1.3

7.42

7.40

0.21

127

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.38

15.24

1.2

1.3

7.39

7.43

0.34

Diffuse large B-cell lymphoma, including Hilmo

4.38

15.24

1.4

7.38

7.43

1.00

Diffuse large B-cell lymphoma

4.38

15.24

1.4

7.38

7.43

1.00

Diffuse large B-cell lymphoma, helper endpoint

4.38

15.24

1.4

7.38

7.43

1.00

Rheumatoid arthritis, including avohilmo

173

892

1.95

15.21

1.2

1.3

7.39

7.42

0.98

120

620

Disorders of lens

293

1072

1.70

15.16

1.3

7.42

7.40

0.95

204

752

Non-small cell lung cancer, squamous, helper endpoint

162

3.39

15.08

1.4

1.3

7.39

7.42

0.36

117

Disorders of gallbladder, biliary tract and pancreas

404

1610

1.56

15.08

1.3

7.40

7.41

0.21

290

1124

Invasive ventilation

157

3.42

15.06

1.4

7.44

7.39

0.96

112

Autoimmune diseases

416

1348

1.57

15.05

1.4

1.3

7.40

0.09

298

946

Bronchiectasis

182

3.23

15.04

1.4

1.3

7.37

7.40

0.47

120

Malignant neoplasm of urinary organs

187

3.18

15.03

1.4

1.3

7.38

7.42

0.59

127

Gastroduodenal ulcer

163

826

1.98

14.96

1.3

7.42

7.40

0.78

117

589

Rheumatoid arthritis

162

722

2.00

14.95

1.2

1.3

7.39

7.41

0.67

112

513

Agranulocytosis

246

2.87

14.91

1.4

7.37

7.41

0.47

165

Diabetes medication

387

1433

1.58

14.89

1.3

7.41

7.40

0.11

266

1004

Malignant neoplasm of urinary organs, including Hilmo

225

2.96

14.84

1.5

1.3

7.38

7.43

0.81

152

Hypokalaemia

253

2.83

14.74

1.3

7.45

7.41

0.87

167

269

1384

1.69

14.69

1.2

1.3

7.37

7.39

0.44

181

978

Alcohol use disorder, Swedish definition

252

1334

1.72

14.68

1.2

1.3

7.37

7.39

0.59

166

941

GI-bleeding

189

1016

1.87

14.67

1.4

1.3

7.41

7.40

0.11

136

718

Reimbursement for rheumatic diseases

227

1281

1.77

14.66

1.3

7.40

7.41

0.53

152

907

Cerebrovascular diseases

349

1516

1.60

14.65

1.3

7.43

7.40

1.57

262

1055

Mental and behavioural disorders due to psychoactive substance use

257

1380

1.71

14.63

1.2

1.3

7.37

7.39

0.74

168

975

Diabetic retinopathy, excluding more controls

127

315

2.27

14.57

1.2

1.3

7.44

7.41

0.89

227

Ischaemic Stroke, excluding all haemorrhages

300

1338

1.66

14.56

1.3

7.42

7.40

0.92

226

931

Other diseases of the digestive system

187

1007

1.87

14.45

1.4

1.3

7.41

7.40

0.05

134

712

Other bacterial intestinal infections, including avohilmo

120

552

2.19

14.41

1.4

1.3

7.41

0.00

374

Gout, strict definition

133

638

2.10

14.39

1.4

1.3

7.42

7.40

0.47

444

Stroke, excluding SAH

307

1355

1.64

14.33

1.3

7.42

7.40

0.76

225

943

Substance abuse

249

1357

1.71

14.20

1.2

1.3

7.37

7.39

0.67

163

956

Other arthritis (FG)

141

695

2.04

14.13

1.3

7.40

0.02

486

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

190

3.08

14.00

1.5

1.3

7.36

7.43

0.91

127

Coagulation defects, purpura and other haemorrhagic conditions

101

438

2.32

13.98

1.4

1.3

7.41

0.09

298

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

212

2.96

13.93

1.3

7.35

7.40

0.61

152

Amyloidosis

5.43

13.78

1.7

1.3

7.45

7.40

0.94

Other disorders of kidney and ureter

338

2.51

13.76

1.2

1.3

7.40

0.04

230

Vocal cord dysfunction

139

3.31

13.73

1.4

1.2

7.38

7.39

0.09

Pain in limb

323

1277

1.61

13.73

1.3

7.41

7.40

0.12

224

891

Disorders of choroid and retina

360

1617

1.56

13.70

1.3

7.41

7.40

0.20

258

1146

Pleural plaque with presence of asbestos

265

2.72

13.60

1.2

1.4

7.36

7.41

1.39

183

Drug-induced neutropenia

143

3.40

13.56

1.3

1.4

7.37

7.40

0.42

Unstable angina pectoris

196

848

1.82

13.55

1.4

1.3

7.42

7.38

1.42

140

600

Sulfasalazine

112

514

2.19

13.54

1.3

1.2

7.42

7.40

0.40

353

Purpura and other haemorrhagic conditions

312

2.55

13.45

1.4

1.3

7.42

7.40

0.29

213

Malignant neoplasm of kidney, except renal pelvis

164

3.20

13.40

1.4

1.3

7.36

7.42

0.68

110

Unspecified misadventure during surgical and medical care

125

3.57

13.37

1.4

7.41

7.39

0.36

ILD, hospital admissions

105

474

2.23

13.28

1.3

7.38

7.40

0.59

322

Second line medication for Crohn's disease

213

1223

1.74

13.26

1.3

7.38

7.41

1.18

147

855

Other interstitial pulmonary diseases

106

481

2.22

13.24

1.3

7.37

7.41

0.82

325

Pure hypercholesterolaemia

302

1189

1.62

13.05

1.3

7.42

7.40

0.90

216

829

Interstitial lung disease

106

484

2.21

13.05

1.3

7.37

7.41

0.77

329

Interstitial lung disease endpoints

106

484

2.21

13.05

1.3

7.37

7.41

0.77

329

Type 2 diabetes, definitions combined

343

1274

1.57

12.90

1.3

7.41

7.40

0.35

231

892

Non-follicular lymphoma

267

2.65

12.84

1.4

7.41

7.40

0.05

181

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

249

1504

1.66

12.80

1.3

7.44

7.40

2.09

188

1054

Alcoholic liver disease

251

2.70

12.73

1.3

7.34

7.39

0.55

182

Disorders of thyroid, IBD co-morbidities

167

2.80

12.70

1.3

1.2

7.42

7.41

0.13

112

Cardiac arrest

4.28

12.69

1.2

7.48

7.36

2.82

L04AX Other immunosuppressants

208

1203

1.73

12.67

1.3

7.39

7.41

0.93

145

839

Use of hypnotics and sedatives

406

1544

1.50

12.63

1.3

7.40

0.18

281

1083

Mental and behavioural disorders due to alcohol

223

1252

1.70

12.61

1.2

1.3

7.37

7.39

0.61

150

882

Mental and behavioural disorders due to alcohol, excluding acute intoxication

200

1137

1.75

12.58

1.2

1.3

7.36

7.39

0.86

132

801

Type 2 diabetes, strict (exclude DM1)

343

1285

1.56

12.45

1.3

7.41

7.40

0.40

231

899

Pneumonia derived septicemia

4.38

12.44

1.4

1.3

7.35

7.39

0.36

Presence of other functional implants

275

1164

1.62

12.26

1.3

7.38

7.40

0.82

206

811

Hypertrophic cardiomyopathy

3.85

12.21

1.2

1.4

7.45

7.38

0.61

Gout, unspecified

134

686

1.97

12.19

1.3

7.42

7.39

0.73

101

476

Osteoporosis

136

642

1.96

12.04

1.4

1.3

7.41

7.43

0.43

106

447

Pneumococcal septicemia

4.36

11.98

1.4

1.3

7.35

7.39

0.42

Other specified/unspecified arthritis

123

616

2.01

11.89

1.3

7.40

0.02

439

Diarrhoea and gastroenteritis of presumed infectious origin

265

1477

1.60

11.88

1.3

7.42

7.40

0.83

195

1030

Viral pneumonia (unknown virus, not influenza)

111

3.55

11.83

1.4

7.40

7.41

0.05

Cardiomyopathy, Hypertrophic obstructive

10.77

11.82

1.1

7.40

7.36

0.20

Abnormalities of heart beat

132

657

1.95

11.81

1.4

1.2

7.45

7.40

2.26

100

440

Cardiomyopathy in other diseases

32.03

11.81

1.5

1.0

7.44

7.41

—

Factors influencing health status and contact with health services

112

258

2.18

11.58

1.4

1.2

7.38

7.39

0.13

176

Alcohol use disorder, ICD-based

184

1057

1.75

11.58

1.2

1.3

7.36

7.39

0.58

121

738

Gastric ulcer

106

509

2.10

11.52

1.3

7.44

7.41

1.52

346

Senile cataract

274

1042

1.60

11.42

1.3

7.42

7.39

0.90

192

730

160

879

1.81

11.38

1.2

1.3

7.39

7.41

0.64

113

617

Osteomyelitis

165

3.01

11.38

1.2

1.4

7.38

7.40

0.13

117

Seropositive rheumatoid arthritis

117

582

2.01

11.36

1.2

1.3

7.39

7.41

0.77

404

Cutaneous abscess, furuncle and carbuncle

111

545

2.05

11.35

1.3

7.40

0.13

377

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

116

581

2.01

11.24

1.2

1.3

7.39

7.42

0.95

402

Hypertensive Renal Disease

3.85

11.22

1.4

7.44

7.40

0.66

Myelodysplastic syndrome, including Hilmo

4.64

11.21

1.5

1.3

7.45

7.44

0.07

Mycoses

124

637

1.95

11.18

1.3

7.42

7.40

0.61

427

Sub-endpoint used in defining T1D endpoints

126

640

1.94

11.15

1.3

7.42

7.40

0.30

436

Sequelae of external causes of morbidity and mortality

125

645

1.95

11.13

1.3

7.40

7.41

0.19

434

Glomerulonephritis

211

2.72

11.13

1.4

7.42

7.39

0.47

152

Other (not insulin) diabetes medications

362

1421

1.50

11.12

1.3

7.41

7.40

0.30

249

998

Type 2 diabetes, definitions combined, including avohilmo

334

1271

1.52

11.04

1.3

7.41

7.40

0.45

224

890

Other diseases of intestines

366

1368

1.49

10.96

1.3

7.41

7.40

0.26

250

968

Abnormal findings on diagnostic imaging of other body structures

283

2.45

10.93

1.5

1.3

7.46

7.42

0.97

190

Covid-19 suspected case

301

2.40

10.92

1.4

1.3

7.41

7.39

0.37

198

Viral pneumonia (known virus, not influenza)

4.17

10.92

1.4

1.3

7.42

7.40

0.17

Other disorders of glucose regulation and pancreatic internal secretion

164

2.95

10.86

1.4

1.3

7.36

7.40

0.28

117

Colorectal cancer

103

480

2.07

10.79

1.3

7.45

7.42

0.90

330

Acute bronchitis

182

1044

1.71

10.74

1.4

1.3

7.41

0.01

134

737

Other soft tissue disorders, not elsewhere classified

342

1295

1.50

10.70

1.3

7.41

7.40

0.25

238

905

Other (seronegative) rheumatoid arthritis, wide

431

2.15

10.69

1.2

1.3

7.39

7.41

0.50

298

Symptoms and signs concerning food and fluid intake

221

2.64

10.66

1.1

1.3

7.42

7.40

0.33

159

Other/unspecified seropositive rheumatoid arthritis

116

595

1.96

10.54

1.2

1.3

7.39

7.42

0.94

412

Colorectal cancer, including Hilmo

110

514

2.00

10.53

1.2

1.3

7.45

7.41

1.08

351

Injuries to the hip and thigh

235

1320

1.60

10.49

1.2

1.3

7.40

0.13

175

928

Diabetic maculopathy, excluding more controls

219

2.62

10.37

1.4

1.3

7.41

7.40

0.03

162

Pain, not elsewhere classified

101

496

2.04

10.36

1.3

7.38

7.40

0.24

350

Seropositive rheumatoid arthritis, wide

117

606

1.94

10.34

1.2

1.3

7.39

7.42

0.90

417

Amyloidosis, other/unspecified

5.01

10.32

1.8

1.3

7.46

7.40

1.24

Biguanides

360

1479

1.47

10.27

1.2

1.3

7.41

7.40

0.21

250

1038

Cellulitis

102

505

2.03

10.26

1.3

7.40

7.41

0.15

347

Hepatic failure, not elsewhere classified

3.85

10.24

1.2

7.44

7.39

1.01

Medicines for HER+ breast cancer

121

590

1.92

10.22

1.3

1.2

7.45

7.44

0.53

415

Diseases of peritoneum

240

2.52

10.07

1.3

1.4

7.42

7.40

0.34

170

Diabetic retinopathy, strict definition

390

2.11

10.00

1.3

7.41

7.40

0.12

265

L02BA Anti-estrogens

235

2.52

9.97

1.2

7.45

7.43

0.70

152

Constipation

355

1651

1.46

9.92

1.3

7.41

7.40

0.01

253

1160

Other embolism and thrombosis

309

2.31

9.91

1.4

1.3

7.38

7.40

0.32

217

Malignant neoplasm of other and unspecified female genital organs

10.88

9.84

1.2

1.1

7.35

7.50

—

Falls/tendency to fall

358

1221

1.47

9.82

1.3

7.41

0.12

232

875

Intestinal stricture

154

884

1.75

9.82

1.3

7.40

7.41

0.07

116

608

Other or ill-defined heart diseases

4.39

9.79

1.3

1.1

7.43

7.38

0.84

Injuries to the abdomen, lower back, lumbar spine and pelvis

180

1063

1.67

9.77

1.3

7.38

7.41

0.75

132

744

Codeine or tramadol medication

409

1560

1.43

9.72

1.3

7.41

7.40

0.16

277

1106

Abnormal results of function studies

153

2.90

9.69

1.4

7.42

7.41

0.05

102

Malignant neoplasm of breast, HER-negative

211

2.56

9.68

1.2

1.1

7.46

7.45

0.02

139

Immunodeficiency with predominantly antibody defects

5.36

9.66

1.4

1.2

7.53

7.38

1.62

Asthma, hospital admissions , main diagnosis only

293

1710

1.49

9.57

1.3

7.41

0.21

197

1215

Benign neoplasm of colon, rectum, anus and anal canal

292

1655

1.49

9.56

1.4

1.3

7.40

7.41

0.01

204

1177

Multiple myeloma, including Hilmo

3.66

9.55

1.1

1.3

7.44

0.06

L02BG Aromatase inhibitors

106

539

1.95

9.54

1.3

1.2

7.45

7.44

0.69

379

Paralytic ileus and intestinal obstruction

131

723

1.82

9.53

1.3

7.40

0.04

514

ILD, hospital admissions 1, main diag only

420

2.09

9.43

1.3

7.37

7.41

0.79

284

Fracture of femur

156

816

1.73

9.43

1.1

1.3

7.41

0.07

115

568

Injuries to the thorax

209

1313

1.60

9.41

1.3

7.41

7.40

0.34

149

916

Hypoglycaemia, other or unspecified

129

3.05

9.38

1.4

1.3

7.39

0.02

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.56

9.33

1.4

1.3

7.48

7.38

1.14

Asthma and opportunity respiratory infection

120

3.13

9.23

1.2

1.3

7.40

7.41

0.10

Retention of urine

194

968

1.63

9.15

1.3

7.37

7.39

0.40

133

687

Finngen Rheumatological endpoints

324

1255

1.47

9.07

1.3

1.2

7.42

7.40

0.95

214

879

Diagnoses used for exclusion with ILD

128

714

1.80

9.05

1.3

7.43

7.40

0.75

486

Myocardial infarction, without ST-elevation

225

1307

1.56

9.04

1.3

7.43

7.40

1.38

164

932

Intestinal infectious diseases, including avohilmo, including avohilmo

423

1689

1.40

9.02

1.3

7.42

7.40

0.92

299

1188

Other CVD

121

665

1.83

8.99

1.3

7.45

7.41

0.97

460

Thyrotoxicosis

476

1.98

8.94

1.3

7.45

7.41

1.66

322

Symptoms and signs involving the urinary system

308

1595

1.46

8.82

1.3

7.41

0.01

220

1128

Polyneuropathies and other disorders of the peripheral nervous system

116

634

1.84

8.79

1.2

1.3

7.41

0.02

431

Symptoms and signs involving the digestive system and abdomen

359

1255

1.44

8.76

1.3

7.40

0.00

243

884

Convulsions, not elsewhere classified

413

2.04

8.74

1.3

7.40

0.09

288

Persons encountering health services in other circumstances, wide

418

1545

1.39

8.66

1.3

7.38

7.41

2.38

294

1088

Persons encountering health services for other counselling and medical advice, not elsewhere classified

402

1529

1.40

8.60

1.3

7.38

7.41

1.78

282

1076

Cholelithiasis, broad definition with cholecystitis

332

1542

1.43

8.56

1.2

1.3

7.41

0.05

233

1082

Amiodarone users

304

2.22

8.55

1.3

7.46

7.40

2.62

216

Thyrotoxicosis with toxic multinodular goitre

131

2.93

8.55

1.3

7.43

7.41

0.19

Status post-ami

139

605

1.75

8.54

1.4

1.3

7.44

7.39

3.08

108

429

Malignant neoplasm of breast, ER-negative, including Hilmo

224

2.39

8.53

1.2

1.1

7.46

0.03

148

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

7.50

8.50

1.1

1.4

7.37

7.44

0.52

Malignant neoplasm of head and neck

143

2.82

8.41

1.4

1.3

7.41

7.43

0.42

Injury of other and unspecified intrathoracic organs

149

2.78

8.39

1.2

1.4

7.37

7.39

0.35

109

Other or unspecified ileus, impaction or obstruction

509

1.91

8.34

1.3

7.42

7.41

0.18

349

Lymphoid leukaemia

144

2.81

8.34

1.6

1.4

7.41

7.39

0.25

Other disorders involving the immune mechanism, not elsewhere classified

4.13

8.28

1.4

7.48

7.38

1.13

Hydronephrosis

251

2.33

8.27

1.1

1.3

7.40

7.39

0.14

172

Other cataract

192

899

1.59

8.25

1.4

1.3

7.40

7.39

0.35

149

633

Fentanyl

251

2.32

8.23

1.5

1.3

7.42

7.43

0.20

176

Other functional intestinal disorders

192

1108

1.58

8.22

1.3

7.41

7.40

0.35

138

789

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

162

2.68

8.22

1.8

1.3

7.47

7.41

2.29

109

Malignant neoplasm, without specification of site

3.95

8.16

1.0

1.3

7.43

7.45

0.23

Chronic pancreatitis

304

2.19

8.13

1.3

7.36

7.40

0.50

208

Lung diseases due to external agents

424

1.99

8.12

1.2

1.3

7.43

7.41

0.41

291

Fracture of rib(s), sternum and thoracic spine

149

897

1.67

8.08

1.2

1.3

7.40

0.01

105

635

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

4.02

8.06

1.2

1.3

7.31

7.39

0.64

Thrombocytopenia, unspecified

170

2.61

8.01

1.5

1.3

7.41

7.40

0.10

119

Other and unspecified types of non-Hodgkin lymphoma, hilmo

104

3.12

8.00

1.3

7.42

7.40

0.17

Diabetic retinopathy

170

648

1.63

7.86

1.3

7.42

7.40

0.28

123

466

Disorders of calcium metabolism

132

2.83

7.85

1.4

1.3

7.39

7.41

0.20

Other disorders of white blood cells

116

2.96

7.82

1.5

1.4

7.37

7.39

0.29

Idiopathic gout

303

2.16

7.80

1.4

1.3

7.37

7.39

0.22

207

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

281

2.19

7.77

1.4

7.45

7.40

1.70

193

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

227

2.35

7.77

1.5

1.3

7.42

7.40

0.39

158

3.59

7.73

1.2

7.33

7.41

0.53

Obesity related asthma

126

734

1.72

7.73

1.2

1.3

7.40

0.11

516

Amputation of foot

3.59

7.73

1.2

1.5

7.41

7.39

0.12

Malignant neoplasm of head and neck, including Hilmo

179

2.53

7.72

1.4

1.3

7.41

7.43

0.32

117

Fracture of lumbar spine and pelvis

116

659

1.76

7.72

1.3

7.36

7.42

1.08

458

Aortic aneurysm

134

779

1.69

7.70

1.3

7.40

7.39

0.31

563

Congenital malformations of heart and great arteries

179

2.50

7.70

1.2

1.4

7.45

7.39

2.07

125

Other infectious diseases, including avohilmo

228

2.34

7.70

1.5

1.3

7.42

7.40

0.20

164

Certain disorders involving the immune mechanism

399

1.99

7.64

1.4

1.3

7.45

7.39

1.98

269

ILD medications: azathioprine

210

2.39

7.64

1.2

1.3

7.42

7.40

0.46

137

Sequelae with surgical and medical care as external cause

518

1.86

7.64

1.3

7.42

7.41

0.39

354

Thyrotoxicosis, other and/or unspecified

360

2.04

7.54

1.4

1.3

7.44

7.40

1.26

242

Malignant neoplasm of oesophagus, including Hilmo

3.57

7.43

1.1

1.4

7.36

7.43

0.37

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

299

2.13

7.42

1.4

1.3

7.43

7.44

0.05

203

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

255

2.21

7.40

1.3

1.4

7.46

7.40

2.46

174

Benzodiazepine use

360

1768

1.38

7.39

1.3

7.37

7.41

2.58

250

1249

Thiazolidinediones

297

2.14

7.36

1.3

7.37

7.40

0.50

207

Other/unspecified rheumatoid arthritis

291

2.14

7.32

1.2

1.3

7.40

7.42

0.38

199

Congenital malformations, deformations and chromosomal abnormalities

160

954

1.59

7.24

1.3

7.45

7.40

2.86

116

650

Other complications of surgical and medical care, not elsewhere classified

179

2.47

7.23

1.3

7.44

7.40

1.40

127

Unspecified fall

204

1333

1.50

7.21

1.3

7.38

7.41

0.88

145

939

Other external causes of accidental injury

275

951

1.45

7.21

1.3

7.41

0.08

174

681

Squamous cell neoplasms and carcinomas of the skin

242

2.24

7.14

1.5

1.3

7.43

0.07

167

Malignant melanoma

288

2.13

7.10

1.2

1.3

7.40

7.43

0.50

198

Disorders of other endocrine glands

152

938

1.60

7.04

1.3

7.44

7.41

1.32

116

648

Oesophageal varices

3.11

7.02

1.3

1.4

7.42

7.41

0.08

Other and unspecified disorders of white blood cells

3.18

7.00

1.5

1.3

7.36

7.38

0.22

Injuries to the head

383

1680

1.35

6.98

1.2

1.3

7.38

7.41

1.28

264

1188

Azathioprine

220

2.28

6.92

1.2

1.3

7.42

7.40

0.46

148

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

114

668

1.71

6.90

1.3

7.44

7.41

0.97

464

Asthma, including avohilmo

411

1694

1.34

6.83

1.2

1.3

7.40

0.05

281

1201

Preparatory care for dialysis

115

2.82

6.76

1.3

1.4

7.32

7.40

0.46

Myocarditis

5.66

6.75

1.3

1.1

7.48

7.37

1.59

Thoracic aortic aneurysm

404

1.92

6.74

1.3

7.37

7.40

0.44

284

Phlebitis and thrombophlebitis (not including DVT)

504

1.81

6.71

1.2

1.3

7.38

7.40

0.26

346

Clear cell adenocarcinoma of kidney

3.24

6.70

1.5

1.3

7.38

7.44

0.60

Diverticular disease of intestine

288

1278

1.40

6.66

1.3

7.42

7.40

0.69

187

913

Malignant neoplasm of colon

323

2.02

6.64

1.3

7.44

7.43

0.13

214

Candidiasis

283

2.09

6.62

1.4

7.42

7.40

0.58

185

Acute pancreatitis

492

1.82

6.61

1.4

1.3

7.34

7.40

1.14

331

Nephrotic syndrome

3.60

6.61

1.3

7.44

7.38

0.46

Secondary right heart disease

111

2.83

6.60

1.4

7.44

7.41

0.30

Use of anticholinesterases

1153

0.56

6.59

1.2

1.3

7.41

0.11

817

N06DA Anticholinesterases

1153

0.56

6.59

1.2

1.3

7.40

7.41

0.11

817

Chronic nephritic syndrome

3.28

6.57

1.5

1.3

7.44

7.40

0.41

Familial hypercholesterolemia

402

1.90

6.50

1.4

1.3

7.42

7.41

0.17

265

Intracranial trauma

184

819

1.52

6.48

1.2

7.41

7.40

0.35

127

546

Accidents

270

951

1.42

6.47

1.3

7.41

0.08

174

681

Substance use, excluding alcohol

313

2.02

6.44

1.2

1.3

7.28

7.39

1.34

215

Complications of cardiac and vascular prosthetic devices, implants and grafts

3.79

6.39

1.5

1.4

7.36

7.38

0.09

Other neurological diseases

295

1660

1.38

6.39

1.3

7.43

7.40

1.79

227

1160

Malignant neoplasm of colon, including Hilmo

382

1.91

6.36

1.3

7.44

7.43

0.17

257

Autoimmune diseases related-to ILD

287

1736

1.38

6.34

1.4

1.3

7.40

7.41

0.33

205

1219

Dermatitis

231

1584

1.43

6.31

1.4

1.3

7.42

7.40

0.33

165

1114

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

161

2.44

6.26

1.3

7.38

7.41

0.26

110

Other and unspecified polyneuropathies, also in other diseases

560

1.74

6.26

1.2

1.3

7.40

0.00

378

Polyarthritis, unspecified

3.15

6.18

1.4

7.39

7.40

0.13

Rare circulating lymphoid malignancy, including Hilmo

4.00

6.18

1.6

1.4

7.45

7.42

0.32

Primary biliary cholangitis, wide definition

5.39

6.17

1.1

1.0

7.43

7.41

0.11

Dentofacial anomalies [including malocclusion]

1046

0.55

6.14

1.4

1.3

7.44

7.41

1.15

721

Pyogenic arthritis

157

2.44

6.11

1.2

1.4

7.46

7.40

2.08

111

Immunodeficiencies

3.10

6.05

1.3

1.2

7.51

7.37

2.18

Candidiasis, including avohilmo

573

1.71

6.04

1.3

7.41

0.02

395

Congenital malformations of the circulatory system

220

2.17

6.04

1.2

1.4

7.45

7.40

1.92

152

Problems related to lifestyle

158

2.42

6.02

1.3

7.37

7.39

0.16

114

Dysphagia

110

666

1.66

5.97

1.3

7.42

7.41

0.19

469

Other and unspecified dermatitis

189

1292

1.47

5.97

1.3

7.41

0.03

135

909

Other other unspecified disorders of the circulatory system

3.07

5.93

1.3

1.2

7.48

7.39

1.92

Other gastritis (incl. Duodenitis)

554

1.72

5.93

1.3

7.39

7.40

0.21

379

Malignant melanoma of skin

216

2.19

5.92

1.2

1.3

7.39

7.43

0.56

144

Hypercalcemia

101

2.80

5.90

1.5

1.3

7.38

7.42

0.33

Seronegative rheumatoid arthritis

236

2.13

5.90

1.2

1.3

7.40

0.09

163

Cholecystitis

380

1.88

5.90

1.2

1.3

7.39

7.41

0.25

261

Renal cell carcinoma of kidney

3.55

5.89

1.2

1.3

7.39

7.43

0.36

Malignant neoplasm of pancreas, including Hilmo

154

2.42

5.86

1.2

1.3

7.36

7.44

1.47

105

Decubitus ulcer and pressure area

192

2.26

5.83

1.3

7.41

7.40

0.10

137

Hypotension

581

1.69

5.78

1.3

7.44

7.41

0.52

402

Benign neoplasms

323

1304

1.35

5.78

1.4

1.3

7.40

0.11

228

916

Other diseases of arteries and capillaries

193

2.24

5.75

1.2

1.3

7.45

7.40

1.38

139

Other spirochaetal diseases

774

0.44

5.75

1.1

1.3

7.43

7.41

0.51

539

Myelodysplastic syndrome

6.23

5.73

1.4

7.50

7.38

—

External causes of morbidity and mortality

201

687

1.47

5.72

1.4

1.3

7.40

7.41

0.18

139

479

Unknown and unspecified causes of morbidity

120

2.60

5.71

1.1

1.4

7.42

7.40

0.39

Other antidepressants

368

1422

1.32

5.68

1.3

7.36

7.41

2.78

248

1024

Lyme disease, including avohilmo

770

0.44

5.68

1.1

1.3

7.43

7.41

0.50

536

Lyme disease

770

0.44

5.68

1.1

1.3

7.43

7.41

0.50

536

Pleural plaque without asbestos

121

2.60

5.65

1.3

1.4

7.35

7.39

0.60

Benign thyroid growths and nodules

119

692

1.60

5.62

1.3

7.41

7.42

0.32

485

Duodenal ulcer

330

1.92

5.61

1.4

1.3

7.40

7.41

0.06

229

195

2.21

5.61

1.3

7.41

0.01

135

Disorders of mineral metabolism

170

2.31

5.59

1.4

1.3

7.40

7.41

0.08

112

Concussion

159

819

1.51

5.59

1.2

7.40

0.09

114

546

Acute myeloid leukaemia and myelodysplastic syndromes

3.86

5.55

1.4

1.2

7.49

7.41

1.17

Other pulmonary heart/vessel disease

122

2.57

5.55

1.4

1.3

7.44

7.41

0.29

Mental and behavioural disorders due to use of other stimulants, including caffeine

10.07

5.53

1.3

1.0

7.20

7.34

—

Use of rivastigmine

588

0.37

5.53

1.2

1.3

7.42

7.43

0.04

412

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

173

1073

1.47

5.53

1.3

7.43

7.40

1.62

124

741

Cholelithiasis

300

1523

1.35

5.52

1.2

1.3

7.41

0.20

212

1069

Spirochaetal infections, other/unspecified, including avohilmo

774

0.45

5.51

1.1

1.3

7.43

7.41

0.50

540

Other symptoms and signs involving the circulatory and respiratory systems

105

2.68

5.49

1.3

7.26

7.40

0.82

Open wound of lower leg

312

1.93

5.46

1.3

7.42

7.40

0.45

216

Other diseases of pancreas

211

2.15

5.44

1.3

1.4

7.38

7.41

0.24

145

Hernia

317

1583

1.33

5.42

1.3

7.41

0.00

217

1121

Other spirochaetal diseases, including avohilmo

782

0.46

5.41

1.1

1.3

7.43

7.41

0.49

546

Pneumonitis due to solids and liquids

252

2.04

5.38

1.3

7.45

7.41

0.82

176

Other and unspecified drugs and medicaments

161

2.31

5.34

1.3

1.4

7.40

7.41

0.06

112

Fracture of lower leg, including ankle

188

1291

1.43

5.29

1.3

7.41

0.01

123

921

Acute pancreatitis (for exclusion)

528

1.69

5.27

1.4

1.3

7.34

7.41

1.27

354

Open wound of head

217

1462

1.40

5.27

1.3

7.38

7.40

0.80

146

1039

Disorder of lipoprotein metabolism, unspecified

324

1.89

5.24

1.2

1.3

7.44

7.41

0.62

210

Malignant melanoma, including Hilmo

331

1.88

5.23

1.2

1.3

7.40

7.43

0.42

221

Persons encountering health services for specific procedures, not carried out

114

2.55

5.20

1.1

1.2

7.32

7.42

0.79

Vascular disorders of the intestines

202

2.14

5.19

1.5

1.3

7.39

7.42

0.32

140

Chronic gastritis

119

763

1.56

5.17

1.3

7.41

7.40

0.08

537

Exposure to unspecified factor

341

1776

1.31

5.15

1.2

1.3

7.41

7.40

0.42

217

1273

Nausea and vomiting

592

1.63

5.15

1.2

1.3

7.44

7.42

0.43

413

Fall involving bed

2.75

5.12

1.2

1.4

7.40

7.39

0.06

Unspecified haematuria

195

1122

1.42

5.09

1.4

1.3

7.40

7.39

0.21

137

786

Seropositive rheumatoid arthritis, strict definition

322

1.87

5.01

1.3

7.34

7.41

1.51

212

In situ neoplasms

163

1125

1.45

4.99

1.2

1.3

7.42

7.41

0.26

111

793

Symptoms and signs involving cognition, perception, emotional state and behaviour

328

1677

1.31

4.99

1.3

7.41

7.40

0.48

227

1181

Pain (limb, back, neck, head abdominally)

258

948

1.37

4.97

1.4

1.3

7.40

0.09

178

661

Diseases of the skin and subcutaneous tissue

323

1231

1.32

4.93

1.3

1.2

7.40

0.04

215

870

Colorectal adenocarcinoma

442

1.72

4.92

1.2

1.3

7.44

7.42

0.34

301

Multiple myeloma and malignant plasma cell neoplasms

136

2.38

4.91

1.3

1.4

7.45

7.40

1.16

Other nutritional deficiencies

196

1280

1.40

4.86

1.2

1.3

7.39

7.40

0.33

142

880

Transient ischemic attack

228

1328

1.37

4.86

1.4

1.3

7.43

7.40

2.10

181

930

Benign neoplasm: Colon

232

1604

1.36

4.83

1.4

1.3

7.41

7.40

0.16

167

1133

Haemorrhage, not elsewhere classified

2.66

4.83

1.1

1.3

7.41

7.39

0.20

Elevated blood glucose level

182

2.15

4.81

1.1

1.3

7.38

7.39

0.17

134

Disorders of parathyroid gland

513

1.66

4.80

1.2

1.3

7.45

7.42

0.95

359

Other skin changes

535

1.65

4.79

1.2

1.3

7.43

7.41

0.75

365

DVT of lower extremities

490

1.68

4.77

1.3

7.42

7.41

0.20

336

Obesity due to excess calories

136

916

1.49

4.73

1.3

7.38

7.40

0.53

103

628

Other infectious diseases

190

2.12

4.72

1.6

1.3

7.40

7.41

0.07

135

Other noninfective gastroenteritis and colitis

529

1.65

4.72

1.2

1.3

7.39

7.41

0.28

356

Corns and callosities

145

2.29

4.70

1.2

1.3

7.44

7.41

0.50

104

Unspecific neurodegenerative disorder

120

1234

0.66

4.70

1.2

1.3

7.43

7.41

0.41

877

Amputation of ankle bones

3.06

4.69

1.2

1.5

7.36

7.38

—

Chronic ulcer of skin, not elsewhere classified

184

2.13

4.69

1.3

7.39

0.04

131

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

184

2.12

4.67

1.1

1.3

7.34

7.40

0.66

127

Malignant melanoma of skin, including Hilmo

266

1.92

4.66

1.2

1.3

7.40

7.43

0.49

179

Artificial opening status

121

2.41

4.64

1.2

1.3

7.45

7.40

0.75

Malignant neoplasm of pancreas

121

2.41

4.63

1.1

1.3

7.37

7.45

1.37

Soft tissue disorders

330

1301

1.30

4.62

1.3

7.42

7.40

0.55

223

911

Malignant neoplasm of rectum

186

2.11

4.56

1.2

1.3

7.46

7.43

0.66

122

Injury, poisoning and certain other consequences of external causes

161

554

1.46

4.54

1.4

1.3

7.40

7.41

0.17

116

383

Occupational exposure to risk-factors

2.75

4.53

1.3

1.5

7.40

7.38

0.22

Examination and observation for other reasons

201

815

1.39

4.52

1.3

1.2

7.39

7.40

0.22

142

539

Degeneration of macula and posterior pole

227

1299

1.35

4.46

1.3

7.42

7.40

0.60

171

929

Primary biliary cholangitis (PBC)

4.43

4.45

1.1

1.0

7.42

—

Viral infections characterized by skin and mucous membrane lesions

138

945

1.46

4.43

1.3

7.42

7.40

0.58

100

648

Intestinal malabsorption

2.70

4.42

1.6

1.3

7.43

7.37

0.70

Familial hypercholesterolemia, with ischemic heart disease

272

1.89

4.40

1.5

1.2

7.41

0.01

181

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

4.71

4.38

1.2

1.4

7.36

7.40

—

Abdominal and pelvic pain

323

1255

1.29

4.36

1.4

1.3

7.40

0.06

229

884

Benign neoplasm: Rectum, anus and anal canal

589

1.58

4.34

1.4

1.3

7.41

7.40

0.13

401

Neuroendocrine tumor and carcinoma of small intestine

5.59

4.31

1.2

1.3

7.54

7.35

—

Other metabolic disorders

184

2.07

4.29

1.4

1.3

7.43

7.41

0.53

112

Any mental disorder

366

1445

1.27

4.28

1.3

7.38

7.41

1.09

258

1031

Genitourinary diseases

185

662

1.40

4.27

1.4

1.2

7.39

7.38

0.09

129

459

Other symptoms and signs involving the digestive system and abdomen

297

1.82

4.23

1.4

1.3

7.38

7.42

0.83

201

Malignant neoplasm of small intestine

4.17

4.22

1.1

1.4

7.50

7.40

—

Diabetic maculopathy

294

1.81

4.20

1.4

1.3

7.40

0.04

208

Viral hepatitis, IBD co-morbidity

3.15

4.20

1.3

1.1

7.32

7.35

0.11

Insulin, fast-acting (human)

234

1.93

4.18

1.3

7.41

0.04

162

Obesity

178

1217

1.38

4.12

1.3

7.39

7.40

0.53

129

831

Alzheimer disease, including avohilmo

108

1113

0.67

4.11

1.2

1.3

7.42

7.41

0.22

798

Malignant neoplasm of other and ill-defined sites, including Hilmo

4.68

4.07

1.1

1.3

7.41

—

Poisoning by drugs, medicaments and biological substances

346

1.74

4.03

1.1

1.3

7.33

7.40

0.91

239

Obesity and other hyperalimentation

179

1229

1.37

4.01

1.3

7.39

7.40

0.54

129

841

Sequelae of cerebrovascular disease

177

1101

1.38

4.01

1.3

7.42

7.40

0.94

137

767

Malignant neoplasm of stomach, including Hilmo

2.44

3.96

1.1

1.3

7.33

7.44

0.91

Osteonecrosis

137

2.20

3.95

1.2

1.5

7.46

7.42

0.51

Delirium, not induced by alcohol and other psychoactive substances

416

1.66

3.93

1.2

1.3

7.39

7.42

0.32

292

Septal defects

2.71

3.85

1.1

1.3

7.45

7.37

1.19

Malignant neoplasm of small intestine, including Hilmo

3.09

3.81

1.3

1.4

7.49

7.41

—

Diseases of the eye and adnexa

216

809

1.34

3.79

1.4

1.3

7.40

7.39

0.35

156

576

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

326

1.73

3.79

1.3

7.38

7.40

0.33

226

Diseases of the musculoskeletal system and connective tissue

152

538

1.42

3.78

1.4

1.2

7.38

7.40

0.41

112

376

Benign neoplasm: Rectum

523

1.57

3.77

1.4

1.3

7.42

7.40

0.41

358

Alcohol dependence

100

667

1.50

3.75

1.3

7.33

7.40

1.36

463

Gastrointestinal diseases

143

501

1.43

3.75

1.4

1.3

7.39

7.40

0.03

103

351

Vascular diseases of the intestine

102

2.37

3.74

1.3

1.2

7.41

7.40

0.11

Neurological diseases, wide definition

183

1.73

3.69

1.3

1.2

7.39

7.40

0.09

123

Other viral hepatitis, including avohilmo

2.80

3.68

1.3

7.32

7.38

0.25

Other diseases of liver

372

1.67

3.65

1.5

1.3

7.39

7.40

0.18

252

Essential (haemorrhagic) thrombocythaemia

2.88

3.63

1.3

7.49

7.43

—

Monoplegia

4.06

3.61

1.2

1.4

7.46

7.37

—

Unspecified jaundice

123

2.21

3.61

1.2

1.3

7.36

7.41

0.40

Sulfonylureas

165

962

1.37

3.58

1.3

7.39

7.40

0.17

119

683

Intracranial injury

205

1452

1.32

3.58

1.3

7.41

7.40

0.19

148

1036

Congenital malformations of cardiac septa

2.53

3.56

1.1

1.3

7.45

7.38

1.20

Low back pain

249

1305

1.29

3.55

1.2

1.3

7.42

7.40

0.80

180

909

Hyperparathyroidism

455

1.59

3.54

1.3

7.46

7.42

1.09

313

Weight loss

256

1.81

3.54

1.1

1.3

7.43

7.41

0.33

177

Other viral diseases

475

1.58

3.51

1.4

1.3

7.42

7.40

0.31

323

Infection of intervertebral disc (pyogenic)

3.94

3.51

1.6

1.2

7.37

7.41

—

Malignant neoplasm of stomach

2.38

3.48

1.1

1.3

7.38

7.44

0.62

Carbimazole or st.post thyroidectomy, condition for graves disease

362

1.66

3.47

1.3

7.44

7.42

0.41

241

Chronic periodontitis, complicated

200

1487

1.31

3.44

1.2

1.3

7.38

7.40

0.63

138

1044

Other viral hepatitis

2.77

3.42

1.3

7.30

7.39

0.34

Systemic connective tissue disorders

120

847

1.42

3.40

1.3

7.39

7.42

0.53

592

Arthropathies

270

1070

1.28

3.40

1.3

1.2

7.42

7.40

0.65

181

745

Mental and behavioural disorders due to opioids

4.09

3.39

1.2

7.40

7.39

—

Use of disulfiram, acamprosate or naltrexone

133

2.11

3.39

1.3

1.5

7.32

7.38

0.48

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

375

1.63

3.38

1.2

1.3

7.35

7.41

0.90

258

malignant neoplasm of male genital organs, including Hilmo

107

438

1.47

3.37

1.3

7.38

0.07

309

194

1329

1.32

3.36

1.3

7.41

0.06

144

934

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

127

2.14

3.35

1.1

1.3

7.44

7.45

0.13

Exclusions for E4_PCOS_BROAD

305

1.71

3.34

1.2

1.4

7.43

7.39

0.86

210

Polyarteritis nodosa and related conditions

4.41

3.32

1.2

1.4

7.43

7.35

—

Paracetamol or NSAID medication

156

1.75

3.31

1.3

7.37

7.39

0.37

111

Other mental disorders due to brain damage and dysfunction and to physical disease

352

1.65

3.31

1.3

1.4

7.38

7.41

0.40

242

Other disorders of skin and subcutaneous tissue, not elsewhere classified

352

1.65

3.31

1.4

1.3

7.40

7.41

0.13

243

Tobacco use

2.42

3.30

1.1

1.3

7.34

7.38

0.17

Chronic viral hepatitis

2.93

3.30

1.2

7.27

7.39

—

Insomnia

161

1495

0.75

3.29

1.3

7.43

7.41

0.51

1058

Noninfective enteritis and colitis

142

1037

1.37

3.28

1.3

7.40

7.41

0.13

103

724

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

326

1693

1.24

3.26

1.3

7.41

7.40

0.39

231

1190

Sequelae of injuries of neck and trunk

2.80

3.26

1.3

1.5

7.40

7.38

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

338

1.66

3.26

1.2

1.4

7.49

7.40

2.08

238

Benign neoplasm: Ascending colon

408

1.60

3.25

1.6

1.3

7.41

7.40

0.16

275

Osteoporosis with pathological fracture (FG)

163

1.97

3.24

1.2

7.46

7.41

1.39

116

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

2.39

3.23

1.1

1.4

7.44

0.01

Pustular psoriasis

2.51

3.21

1.1

1.4

7.32

7.39

0.43

Other and unspecified coagulation defects

2.51

3.21

1.4

1.2

7.36

7.38

0.11

Spondylopathies

274

1288

1.26

3.20

1.3

7.38

7.40

0.55

188

899

Noninfectious colitis NAS

272

1.73

3.20

1.3

1.4

7.39

7.42

0.27

186

Dizziness and giddiness

256

1579

1.26

3.19

1.3

7.41

7.40

0.14

182

1116

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.32

3.17

1.0

1.4

7.44

0.04

Acute upper respiratory infections of multiple and unspecified sites

230

1313

1.28

3.16

1.3

7.39

7.41

0.41

164

919

Postmenopausal bleeding

301

0.52

3.16

1.2

7.41

7.46

0.31

212

General examination and investigation of persons without complaint and reported diagnosis

209

833

1.30

3.15

1.3

1.2

7.42

7.40

0.77

161

550

Adenocarcinoma and papilloma adenocarcinoma of rectum

186

1.89

3.14

1.2

1.3

7.48

7.42

1.43

122

Other special examinations and investigations of persons without complaint or reported diagnosis

214

835

1.30

3.14

1.4

1.2

7.41

7.40

0.68

169

551

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

396

1.59

3.13

1.2

1.3

7.45

7.40

0.67

272

Abdominal aortic aneurysm (AAA)

347

1.64

3.13

1.4

1.3

7.41

7.39

0.27

254

Other and unspecified tonsillitis

334

1.59

3.11

1.4

1.3

7.38

7.39

0.12

236

Cerebral palsy and other paralytic syndromes

230

1.79

3.11

1.2

1.4

7.38

7.40

0.20

159

Postprocedural endocrine and metabolic disorders, not elsewhere classified

166

1.93

3.08

1.4

1.3

7.44

7.41

0.89

101

Methotrexate

253

1.74

3.07

1.4

1.3

7.40

0.01

173

Other menopausal disorders

272

0.49

3.06

1.5

1.2

7.35

7.45

0.78

188

False labour

124

0.30

3.06

1.2

7.33

7.44

—

Poisoning by medicine

291

1.69

3.05

1.1

1.3

7.36

7.40

0.46

201

malignant neoplasm of male genital organs

104

434

1.45

3.05

1.3

1.4

7.37

7.38

0.12

306

Actinic keratosis

183

1278

1.30

3.04

1.3

7.40

7.41

0.20

138

897

Superficial injury of hip and thigh

377

1.60

3.01

1.4

1.3

7.39

7.41

0.25

256

Vitreous haemorrhage

255

1.73

3.00

1.2

1.4

7.37

7.40

0.20

179

Supplementary factors related to causes of morbidity and mortality classified elsewhere

101

709

1.43

3.00

1.3

7.37

7.40

0.66

476

Dorsalgia

308

1323

1.23

3.00

1.3

7.40

0.02

210

922

Atopic dermatitis

812

0.66

2.99

1.3

1.2

7.37

7.40

0.36

556

Acute posthaemorrhagic anaemia

2.42

2.97

1.1

1.3

7.41

7.38

0.22

Other viral diseases, including avohilmo

597

1.46

2.96

1.4

1.3

7.42

7.39

0.59

399

Migraine, single triptan purchase ok & required. ICD-code if available is included

917

0.70

2.96

1.2

7.40

7.41

0.34

627

Triptan medication for migraine, single purchase ok

917

0.70

2.96

1.2

7.40

7.41

0.34

627

Dementia in Alzheimer disease

645

0.61

2.96

1.2

1.3

7.41

0.06

459

Other diseases of intestine

403

1.57

2.94

1.2

1.3

7.40

0.03

278

SLE (Finngen)

2.84

2.92

1.1

1.0

7.48

7.38

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

164

1205

1.31

2.91

1.4

1.3

7.39

0.06

112

854

Symptoms and signs involving the skin and subcutaneous tissue

232

1745

1.26

2.89

1.2

1.3

7.40

7.41

0.10

166

1230

Malignant neoplasm of rectum, including Hilmo

243

1.73

2.89

1.2

1.3

7.46

7.43

0.92

164

Epilepsy

109

779

1.40

2.89

1.2

1.3

7.43

7.40

0.81

530

Fracture of shoulder and upper arm

126

924

1.36

2.89

1.2

1.3

7.38

7.41

0.76

644

Zoster [herpes zoster]

493

1.51

2.89

1.4

1.3

7.43

7.41

0.37

332

Chronic diseases of tonsils and adenoids

121

1040

0.73

2.87

1.2

7.40

0.06

734

Skin changes due to chronic exposure to nonionizing radiation

184

1293

1.29

2.84

1.3

7.40

7.41

0.22

138

907

Caries of enamel

180

1515

0.78

2.84

1.2

1.3

7.40

0.01

104

1078

Dermatophytosis

352

1.60

2.83

1.3

7.43

7.39

0.78

246

Persons encountering health services for examination and investigation

213

835

1.28

2.83

1.4

1.2

7.41

7.40

0.38

160

551

149

965

1.33

2.83

1.2

1.3

7.44

7.41

1.02

114

683

Periodontitis

323

1694

1.22

2.83

1.3

7.40

7.41

0.25

229

1185

Chronic periodontitis, including avohilmo

323

1696

1.22

2.83

1.3

7.40

7.41

0.24

230

1186

Viral and other specified intestinal infections, including avohilmo

376

1.56

2.82

1.3

1.2

7.42

7.39

0.62

253

Systemic lupus erythematosus, unspecified

3.36

2.81

1.1

1.2

7.48

7.35

—

Injuries to unspecified part of trunk, limb or body region

223

1.76

2.81

1.4

1.3

7.42

7.40

0.37

157

Other specified/unspecified systemic involvement of connective tissue

2.23

2.80

1.3

1.2

7.44

7.40

—

Embolic stroke with flimmer

2.66

2.79

1.1

1.2

7.33

7.34

—

Symptoms and signs involving the nervous and musculoskeletal systems

195

1531

1.27

2.78

1.3

7.41

7.40

0.31

152

1065

Unspecified privation

232

1.73

2.75

1.2

1.4

7.39

7.40

0.11

163

Fibroblastic disorders

672

1.42

2.74

1.4

1.3

7.41

7.39

0.36

470

Alzheimer disease

102

1009

0.72

2.73

1.2

1.3

7.41

0.01

719

Sleep disorders

176

1552

0.78

2.71

1.3

7.43

7.41

0.43

107

1100

L01XX Other antineoplastic agents

153

1.91

2.70

1.2

1.4

7.42

7.40

0.19

106

Speech therapy

624

1.43

2.70

1.7

1.3

7.41

0.04

419

Suicide or other Intentional self-harm

396

1.54

2.70

1.2

1.3

7.35

7.40

0.68

272

Mental disorders, not otherwise specified

2.24

2.70

1.2

1.3

7.27

7.39

—

Bacterial, viral and other infectious agents, including avohilmo

132

1.98

2.69

1.5

1.4

7.43

7.38

0.47

Alzheimer’s disease (Late onset)

846

0.68

2.67

1.2

1.3

7.42

7.41

0.11

600

Use of donepezil

783

0.64

2.66

1.2

1.3

7.40

7.42

0.26

542

Bacterial, viral and other infectious agents

126

1.99

2.65

1.5

1.4

7.43

7.38

0.54

Ulcer of oesophagus

183

1.81

2.65

1.5

1.3

7.44

7.41

0.47

131

Arterial embolism and thrombosis

147

1.91

2.65

1.4

1.3

7.43

7.41

0.34

103

Schizophrenia or delusion, excluding more controls

521

1.46

2.64

1.1

1.3

7.36

7.41

1.10

353

Benign neoplasm: salivary glands, exclude unknown (D119)

198

1.78

2.63

1.4

1.3

7.38

7.40

0.16

137

Lower back pain or/and sciatica

343

1779

1.20

2.62

1.3

7.42

7.40

0.85

244

1251

Fall on and from stairs and steps

604

1.43

2.60

1.2

1.3

7.37

7.41

0.77

411

Malignant neoplasm of bladder, including Hilmo

301

1.61

2.60

1.6

1.4

7.41

7.42

0.30

207

Inflammatory diseases of the central nervous system

148

1.90

2.60

1.1

1.4

7.35

7.40

0.38

103

Persons with potential health hazards related to communicable diseases

492

1.47

2.60

1.2

1.3

7.37

7.40

0.34

332

Complications of internal orthopaedic prosthetic devices, implants and grafts

638

1.41

2.59

1.3

7.41

7.40

0.21

447

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

199

1.76

2.59

1.2

1.3

7.48

7.43

1.38

131

Alzheimer’s disease, strict definition

881

0.69

2.58

1.2

1.3

7.41

0.05

629

Conjunctivitis (acute, non atopic), including avohilmo

224

1676

0.81

2.57

1.3

7.40

0.04

139

1193

Colon adenocarcinoma

252

1.67

2.57

1.2

1.3

7.40

7.44

0.53

166

Palmar fascial fibromatosis [Dupuytren]

515

1.46

2.57

1.4

1.3

7.41

7.39

0.28

357

Personality disorders, excluding more controls

329

1.58

2.56

1.2

1.3

7.27

7.41

1.99

224

Diseases of salivary glands

673

1.40

2.56

1.3

7.41

7.40

0.08

461

Other necrotizing vasculopathies

178

1.81

2.55

1.5

1.4

7.40

7.41

0.22

123

Specific personality disorders

299

1.61

2.54

1.2

1.3

7.31

7.40

1.34

205

Systemic lupus erythematosus

2.61

2.53

1.1

1.2

7.48

7.37

—

Degenerative diseases of the nervous system

114

1100

0.74

2.52

1.2

1.3

7.40

7.41

0.14

790

Viral and other specified intestinal infections

277

1.62

2.52

1.2

1.3

7.45

7.39

1.55

189

Type of accident

658

1.40

2.52

1.4

1.3

7.38

7.41

0.55

441

Other diseases of biliary tract

216

1.72

2.51

1.2

1.3

7.40

7.41

0.09

150

Psychiatric diseases

317

1317

1.21

2.51

1.3

7.38

7.41

0.89

216

937

Contraceptive management

396

0.58

2.50

1.2

1.3

7.41

7.39

0.18

279

Malignant neoplasm of prostate, including Hilmo

102

433

1.39

2.50

1.3

7.37

7.38

0.13

308

Behavioural syndromes associated with physiological disturbances and physical factors

188

1598

0.79

2.49

1.2

1.3

7.41

0.00

118

1132

Malignant neoplasm of bone and articular cartilage, including Hilmo

3.49

2.48

1.2

1.3

7.44

7.40

—

Disease of hard tissues of teeth, NOS

128

886

0.76

2.47

1.3

7.39

7.41

0.29

634

Other specified and unspecified personality disorders

102

2.06

2.47

1.1

1.4

7.36

7.38

0.13

Abscess of anal and rectal regions

144

1.88

2.46

1.3

7.42

7.39

0.45

102

Acute sinusitis

129

887

1.32

2.45

1.3

7.38

7.40

0.42

614

SLE, strict definition

2.68

2.45

1.1

1.2

7.48

7.36

—

SLE, ICD10

2.68

2.45

1.1

1.2

7.48

7.36

—

Other local infections of skin and subcutaneous tissue

218

1.70

2.44

1.4

1.3

7.39

7.40

0.21

153

Spondyloarthritis

390

1.52

2.44

1.4

1.3

7.37

7.41

0.37

262

Other symptoms and signs involving cognitive functions and awareness

189

1333

1.26

2.44

1.2

1.3

7.44

7.40

2.29

130

955

Disorders of the thyroid gland

301

1624

1.20

2.43

1.3

7.40

0.13

213

1133

Need for other prophylactic measures

110

2.01

2.41

1.1

1.4

7.40

—

Heterophoria

117

1.97

2.40

1.3

1.4

7.36

7.41

0.66

Carcinoma in situ of other and unspecified genital organs

3.36

2.40

1.2

1.1

7.44

7.40

—

Use of other anti-dementia drugs

959

0.72

2.39

1.2

1.3

7.40

7.41

0.31

670

Use of memantine

959

0.72

2.39

1.2

1.3

7.40

7.41

0.31

670

Myeloproliferative diseases

212

1.71

2.39

1.3

7.42

7.40

0.35

149

Use of biperiden

2.12

2.38

1.1

1.3

7.35

7.40

0.24

Other dorsopathies, not elsewhere classified

306

1323

1.20

2.37

1.3

7.40

0.05

212

922

Acute alcohol intoxication

641

1.39

2.37

1.1

1.3

7.38

7.40

0.33

445

Tubulo-interstitial nephritis, not specified as acute or chronic

132

1.90

2.35

1.4

1.3

7.36

7.39

0.20

Benign neoplasm: Parotid gland

183

1.76

2.35

1.5

1.3

7.37

7.41

0.26

126

Malignant neoplasm of prostate

425

1.38

2.34

1.3

1.4

7.37

7.38

0.21

302

Sequelae of injuries, of poisoning and of other consequences of external causes

485

1.45

2.32

1.4

1.3

7.37

7.40

0.59

325

Benign neoplasm: Small intestine

105

2.01

2.31

1.0

1.3

7.50

7.39

2.19

Spinal stenosis

202

1200

1.24

2.29

1.2

1.3

7.41

0.08

140

845

Cyst of kidney

185

1.74

2.28

1.2

1.3

7.37

7.40

0.27

126

Diseases of inner ear

120

1498

0.77

2.27

1.4

1.3

7.40

7.41

0.31

1065

Nerve, nerve root and plexus disorders

344

1750

1.18

2.27

1.3

7.41

7.40

0.16

253

1220

Mental and behavioural disorders due to tobacco

163

1.79

2.26

1.2

1.4

7.26

7.40

1.29

117

Bronchitis, not specified as acute or chronic

163

1.78

2.26

1.1

1.3

7.45

7.40

1.39

113

Left bundle-branch block

113

1.95

2.25

1.5

1.2

7.44

7.36

0.93

Persons encountering health services in other circumstances

117

878

1.32

2.25

1.3

7.39

7.41

0.64

622

Other endocrine disorders

2.36

2.23

1.3

1.4

7.42

7.36

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

423

1.47

2.23

1.2

1.3

7.35

7.40

0.68

291

Amputation of thigh

2.11

2.23

1.7

1.4

7.45

7.40

—

Medical observation and evaluation for suspected diseases and conditions

203

835

1.24

2.21

1.3

1.2

7.40

0.22

147

551

Statin medication

166

736

1.27

2.21

1.4

1.3

7.41

7.40

0.33

113

527

Dental pulpitis, including avohilmo

161

1298

0.79

2.21

1.2

1.3

7.39

7.40

0.34

107

897

Other and unspecified local infections of skin and subcutaneous tissue

202

1.69

2.20

1.4

1.3

7.39

7.40

0.18

145

Postmenopausal atrophic vaginitis

292

0.60

2.20

1.4

1.2

7.42

7.45

0.69

204

Conductive and sensorineural hearing loss

281

1560

1.20

2.19

1.3

7.41

7.40

0.24

214

1088

Benign neoplasm of other and unspecified endocrine glands

296

1.56

2.18

1.3

1.4

7.39

7.40

0.09

198

Urinary track infection

111

414

1.34

2.17

1.2

7.42

7.45

0.73

296

Female genital prolapse

310

0.61

2.16

1.2

7.46

0.00

218

Dissocial personality disorder

4.32

2.15

1.3

1.2

7.29

7.39

—

Other maternal disorders predominantly related to pregnancy

439

0.65

2.14

1.1

1.2

7.42

7.44

0.31

300

Cholangitis (primary sclerosing, PSC)

152

1.78

2.12

1.2

1.4

7.36

7.41

0.47

105

Disorders of adult personality and behaviour

379

1.48

2.11

1.2

1.3

7.27

7.40

1.93

257

Carcinoma in situ of skin of scalp and neck

102

1.98

2.11

1.4

7.32

7.40

0.66

Viral hepatitis, including avohilmo

2.05

2.11

1.3

7.35

7.37

0.08

Abnormal weight loss

236

1.62

2.10

1.2

1.4

7.43

7.41

0.33

160

Coxarthrosis [arthrosis of hip](FG)

202

1132

1.23

2.10

1.4

1.3

7.41

7.40

0.16

153

800

Neurological diseases

247

1026

1.21

2.08

1.4

1.3

7.40

0.03

175

690

Migraine

633

0.69

2.08

1.3

1.2

7.43

7.41

0.60

422

Injuries to the knee and lower leg

368

1706

1.17

2.08

1.3

7.41

7.40

0.32

245

1211

Sleep apnoea

302

1610

1.18

2.08

1.3

7.40

7.41

0.30

214

1129

Smoking dependency

168

1.73

2.07

1.2

1.4

7.26

7.40

1.28

120

Malignant neoplasm of liver and intrahepatic bile ducts

2.33

2.05

1.0

1.4

7.48

7.43

—

Benign neoplasm of other and ill-defined parts of digestive system

448

1.43

2.05

1.2

1.3

7.45

7.40

1.39

308

Other strabismus

348

1.49

2.04

1.3

7.39

7.40

0.13

235

Benign neoplasm: Adrenal gland

184

1.69

2.04

1.3

1.4

7.35

7.40

0.28

121

Other coagulation defects

132

1.82

2.03

1.3

1.4

7.38

7.41

0.29

Papillary adenocarcinoma of thyroid gland

2.41

2.02

1.2

1.1

7.45

7.44

0.02

Meningitis

2.06

2.01

1.2

1.3

7.29

7.40

0.73

Exclusions for E4_PCOS_CONSORTIUM

151

746

1.26

2.00

1.2

1.3

7.43

0.06

530

Injury of unspecified body region

170

1.71

2.00

1.5

1.3

7.45

7.41

0.66

120

Unspecified mental disorder

748

1.32

1.99

1.2

1.3

7.37

7.40

0.57

518

Papulosquamous disorders

120

933

1.29

1.97

1.4

1.3

7.40

7.41

0.16

649

Other/unspecified dorsalgia

114

870

1.30

1.96

1.3

7.42

7.41

0.16

615

Mycoses, including avohilmo

276

1778

1.18

1.96

1.3

7.40

0.02

191

1251

Schizophrenia or delusion

562

1.37

1.95

1.1

1.3

7.36

7.40

0.74

382

Viral hepatitis

2.03

1.95

1.3

7.34

7.40

0.25

Other reaction to severe stress, and adjustment disorders

511

1.39

1.94

1.3

7.41

7.40

0.13

341

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

4.59

1.94

1.4

1.1

7.50

7.33

—

Respiratory disorders in diseases classified elsewhere

2.99

1.94

1.6

1.3

7.37

7.39

—

Benign neoplasm of major salivary glands

226

1.60

1.93

1.4

1.3

7.38

7.40

0.17

157

Alcohol-induced chronic pancreatitis

142

1.77

1.93

1.3

1.4

7.21

7.41

1.27

105

Dorsopathies

307

1323

1.18

1.92

1.3

7.40

0.02

208

922

Open wound of ankle and foot

195

1.65

1.92

1.2

1.4

7.37

7.38

0.06

138

Other diseases of oesophagus

242

1.57

1.92

1.3

7.44

7.41

0.42

168

Fitting and adjustment of other devices

115

785

1.29

1.91

1.3

1.2

7.39

7.41

0.36

534

Reactive arthropathies, FINNGEN

106

1.89

1.90

1.2

1.3

7.41

7.38

0.26

Nontoxic multinodular goitre

422

1.42

1.89

1.2

1.3

7.42

7.41

0.12

300

Zoster [herpes zoster], including avohilmo

177

1397

1.22

1.88

1.3

7.41

0.04

126

988

Sensorineural hearing loss

272

1537

1.18

1.88

1.3

7.41

7.40

0.41

208

1072

Gonarthrosis, primary, with knee surgery

158

1515

0.81

1.88

1.3

7.39

7.41

0.29

122

1074

Idiopathic pulmonary fibrosis

252

1.55

1.86

1.4

1.3

7.33

7.41

1.40

178

Schizophrenia, schizotypal and delusional disorders

567

1.36

1.86

1.1

1.3

7.36

7.40

0.75

385

Arterial embolism and thrombosis of lower extremity artery

2.04

1.85

1.6

1.3

7.45

7.39

—

Use of galantamine

277

0.50

1.84

1.1

1.3

7.44

7.41

—

191

Erectile dysfunction

277

1.52

1.84

1.3

1.4

7.40

0.01

202

Shoulder lesions

246

1240

1.19

1.83

1.2

1.3

7.41

7.40

0.18

174

864

102

732

1.30

1.83

1.2

1.3

7.44

7.41

0.96

513

Heartburn

222

1.58

1.81

1.5

1.3

7.37

7.42

0.60

150

Small fibre neuropathy

2.07

1.81

1.1

1.3

7.39

7.37

—

Personality disorders

360

1.45

1.80

1.2

1.3

7.27

7.40

1.88

243

Other viral diseases, not elsewhere classified

302

1.49

1.79

1.3

7.40

0.01

208

Benign lipomatous neoplasm

715

0.70

1.79

1.3

7.39

7.41

0.32

487

Cholecystectomy

231

1653

1.19

1.78

1.2

1.3

7.42

7.41

0.59

163

1175

Hernia of abdominal wall

152

1233

1.23

1.78

1.3

7.42

7.39

0.75

104

864

Thyrotoxicosis with diffuse goitre

223

1.57

1.78

1.2

1.3

7.46

7.41

0.80

151

Keratitis

102

789

1.29

1.78

1.2

1.3

7.43

7.40

0.64

540

Bacterial meningitis

2.18

1.78

1.1

1.3

7.28

7.39

—

Abnormalities of gait and mobility

353

1.45

1.78

1.1

1.3

7.37

7.41

0.51

239

Ventral hernia

625

1.33

1.76

1.3

7.41

0.05

424

Oesophagitis

124

1.78

1.76

1.2

1.3

7.34

7.41

0.33

Other disorders of urethra and urinary system

231

1354

1.19

1.75

1.2

1.3

7.42

7.40

0.49

155

976

Arthropathies in other diseases classified elsewhere

2.04

1.75

1.1

1.3

7.28

7.39

—

Assault by bodily force

2.03

1.74

1.2

1.3

7.43

7.35

—

Benign neoplasm: Sigmoid colon

540

1.35

1.74

1.4

1.3

7.43

7.41

0.23

366

Hepatocellular carcinoma, including Hilmo

2.23

1.74

1.1

1.4

7.47

7.42

—

Rash and other nonspecific skin eruption

201

1.60

1.73

1.2

1.4

7.41

0.03

134

Combinations of oral blood glucose lowering drugs

766

1.29

1.73

1.3

7.41

7.39

0.53

531

Sarcoidosis

273

1.51

1.73

1.5

1.3

7.43

7.40

0.64

183

Diaphragmatic hernia

127

1014

1.25

1.73

1.3

7.40

7.41

0.21

712

Benign neoplasm: Rectosigmoid junction

103

1.85

1.72

1.2

1.4

7.31

7.41

0.53

Exposure to other and unspecified inanimate mechanical forces

125

1.76

1.71

1.2

1.4

7.38

7.40

0.18

Malignant neoplasm of corpus uteri

103

1.85

1.71

1.3

1.1

7.44

7.47

0.29

Other disorders of ear

292

1624

1.16

1.70

1.2

1.3

7.41

7.40

0.09

211

1130

Erosion of teeth , including avohilmo

445

0.63

1.69

1.4

1.3

7.41

7.40

0.11

293

Mandibular retrognathia

0.00

1.69

0.0

1.2

—

7.38

—

Other condition

283

1.49

1.68

1.4

7.37

7.40

0.35

195

Persons encountering health services in circumstances related to reproduction

654

0.75

1.68

1.2

1.3

7.45

7.40

1.47

446

Reactive arthropathies

164

1.65

1.67

1.2

1.3

7.41

7.39

0.24

119

Hypocalcemia

2.52

1.67

1.2

1.3

7.44

7.33

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

3.18

1.66

1.0

1.1

7.45

7.39

—

Motorcycle rider injured in other and unspecified transport accidents

2.10

1.65

1.5

1.4

7.39

—

Chronic iridocyclitis

1.93

1.64

1.1

1.3

7.43

7.37

0.74

Acute alcohol intoxication, ICD10

444

1.38

1.63

1.1

1.3

7.36

7.39

0.36

306

Temporomandibular joint disorders, including avohilmo

645

0.70

1.62

1.4

1.3

7.46

7.41

1.37

436

Family history of malignant neoplasm

135

1.71

1.62

1.1

1.4

7.45

7.39

0.66

Right hemicolectomy

166

1.63

1.61

1.3

7.43

7.40

0.30

115

Acute and transient psychotic disorders

166

1.63

1.61

1.1

1.4

7.39

7.40

0.17

117

Inguinal hernia

208

1165

1.19

1.59

1.4

1.3

7.39

0.06

152

813

Budesonide

230

1.52

1.59

1.3

7.48

7.39

1.39

154

Other factor of the environment

3.02

1.58

1.2

1.4

7.31

7.39

—

Disorders of vestibular function (Vertigo)

106

1296

0.80

1.58

1.4

1.3

7.40

7.41

0.34

929

Recurrent or chronic depression

501

0.72

1.56

1.3

7.36

7.41

0.64

356

Collagenous colitis

199

1.56

1.2

1.4

7.41

7.42

0.14

132

Other symptoms and signs involving the nervous and musculoskeletal systems

121

974

1.24

1.56

1.4

1.3

7.44

7.40

1.51

102

670

Sequelae of injuries of lower limb

152

1.65

1.56

1.2

1.4

7.37

7.39

0.21

108

Psoriasis

638

1.30

1.56

1.4

1.3

7.40

0.05

435

Acute upper respiratory infections

328

1718

1.14

1.55

1.3

7.39

7.41

0.58

234

1217

Tuberculosis

176

1.60

1.54

1.4

7.40

7.42

0.11

127

Burns and corrosions

240

1.50

1.54

1.4

1.3

7.40

7.39

0.11

171

Disorders of sclera, cornea, iris and ciliary body

157

1302

1.21

1.53

1.3

7.43

7.40

0.86

110

911

Nonalcoholic fatty liver disease

153

1.64

1.53

1.7

1.4

7.41

7.39

0.31

106

Diseases of the myoneural junction and muscle

323

1.43

1.52

1.3

7.36

7.41

0.68

227

Other abnormal products of conception

154

0.51

1.52

1.5

1.2

7.40

7.43

—

105

Tinnitus

574

0.70

1.51

1.2

1.3

7.36

7.40

0.52

387

Biological medication for rheuma

225

1.51

1.3

7.38

7.39

0.10

150

Tumor necrosis factor alpha inhibitors

185

1.57

1.50

1.3

1.4

7.38

7.40

0.15

124

Other/unspecified reactive arthropathies

108

1.76

1.50

1.2

1.4

7.42

7.39

0.14

Kela-code for severe mental illness

686

1.28

1.50

1.1

1.3

7.37

7.40

0.70

473

Olecranon bursitis

154

1.63

1.50

1.8

1.3

7.26

7.38

0.61

110

Other diseases of stomach and duodenum

154

1.63

1.50

1.2

1.3

7.42

7.41

0.12

112

Complications of labour and delivery

482

0.75

1.49

1.1

1.2

7.41

7.44

0.56

329

Urethral stricture

186

1.57

1.48

1.3

1.4

7.43

7.38

1.34

137

Tuberculosis, IBD comorbidity

194

1.55

1.48

1.5

1.3

7.41

7.42

0.09

138

Focal epilepsy

504

1.33

1.47

1.2

1.3

7.43

7.41

0.50

330

Superficial injury of head

573

1.31

1.47

1.3

7.35

7.41

0.99

391

Attention to artificial openings

1.85

1.46

1.1

1.2

7.26

7.41

—

Carcinoma in situ of skin of other and unspecified parts of face

293

1.44

1.46

1.3

7.37

7.41

0.54

203

Benign neoplasm of bone and articular cartilage

132

1.67

1.45

1.3

7.36

7.40

0.30

Eosinophilia

2.52

1.45

1.3

1.4

7.40

7.35

—

Coxarthrosis

180

976

1.19

1.45

1.4

1.2

7.41

7.40

0.01

137

693

Superficial injury of abdomen, lower back and pelvis

318

1.42

1.45

1.3

7.36

7.40

0.35

222

Recurrent aphthous stomatitis , including avohilmo

285

1.44

1.2

1.4

7.44

7.41

0.40

190

Leisure time condition

403

1.37

1.44

1.2

1.3

7.37

7.41

0.42

276

Hypothyroidism, strict autoimmune

203

1132

1.18

1.44

1.3

7.41

0.06

146

800

Nonorganic sleeping disorders, excluding more controls

302

1.43

1.1

1.3

7.38

7.42

0.45

204

Other noninfective disorders of lymphatic vessels and lymph nodes

2.04

1.43

1.2

7.47

7.41

—

Disorders of continuity of bone

156

1.61

1.43

1.6

1.4

7.35

7.41

0.40

104

Hypermetropia

110

1.73

1.42

1.2

1.4

7.39

0.02

Other anxiety disorders

602

1.27

1.42

1.2

1.3

7.33

7.41

1.48

407

Other disorders of veins

118

945

1.23

1.41

1.3

7.40

7.41

0.19

670

Somnolence, stupor and coma

103

1.75

1.41

1.1

1.4

7.36

7.39

0.28

Infective dermatitis

262

1.45

1.40

1.4

1.3

7.44

7.40

0.53

182

Degenerative macular diseases

329

1.40

1.4

1.3

7.41

0.01

220

Alcohol abuse, main dg, excluding more controls

287

1.43

1.40

1.1

1.3

7.39

7.41

0.17

195

Abnormal serum enzyme levels

127

1006

1.22

1.40

1.2

1.3

7.43

7.39

2.01

717

Chronic apical periodontitis

335

1658

1.13

1.39

1.3

7.39

7.41

0.41

223

1180

Myocardial infarction, with ST-elevation

597

1.29

1.39

1.4

1.3

7.41

0.04

411

Disorders of ocular muscles, binocular movement, accommodation and refraction

113

909

1.23

1.39

1.3

7.40

0.01

620

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

189

1.54

1.39

1.3

7.41

0.03

132

Crohn's disease NAS

1.78

1.39

1.4

1.3

7.40

7.41

0.04

Gastro-oesophageal reflux disease

202

1458

1.17

1.38

1.3

7.40

0.13

144

1040

Fracture of foot, except ankle

441

1.34

1.38

1.2

1.3

7.41

7.39

0.29

297

Visual field defects

206

1.51

1.37

1.2

1.4

7.38

7.41

0.25

140

Fracture of neck

158

1.59

1.37

1.3

1.4

7.43

7.41

0.17

115

Alcohol withdrawal state with delirium

158

1.59

1.37

1.0

1.4

7.35

7.40

0.26

117

Dental operations

224

989

1.17

1.37

1.3

7.41

0.00

157

689

Presbycusis

522

1.31

1.36

1.4

1.3

7.42

0.02

357

Carcinoma in situ of skin of upper limb, including shoulder

1.84

1.36

1.1

1.4

7.43

7.39

—

Other blood glucose lowering drugs, excl. Insulins

425

1.34

1.36

1.3

7.45

7.40

1.19

295

Other headache syndromes

844

0.77

1.35

1.3

1.2

7.40

7.41

0.16

575

Polycystic ovarian syndrome, consortium definition

133

627

1.22

1.35

1.2

7.45

7.44

0.10

444

Female infertility, tubal origin

0.00

1.33

0.0

1.2

—

7.41

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

917

0.80

1.32

1.3

7.38

7.41

0.57

631

Chronic sinusitis

113

922

1.22

1.32

1.4

1.3

7.45

7.40

1.37

648

Suggestive for eosinophilic asthma

208

1.49

1.32

1.4

7.39

7.40

0.04

146

Varicose veins

203

1317

1.16

1.32

1.3

7.41

0.14

143

940

Colectomy operation

471

1.32

1.31

1.2

1.3

7.43

7.41

0.27

321

Other and unspecified nonorganic psychotic disorders

250

1.44

1.30

1.1

1.3

7.31

7.40

0.82

171

Other specified/unspecified bacterial intestinal infections

129

1.63

1.30

1.4

1.3

7.39

7.41

0.22

Open wound of forearm

209

1.49

1.30

1.5

1.3

7.34

7.40

0.98

146

Schizophrenia

267

1.43

1.29

1.0

1.3

7.42

7.40

0.27

182

Disorders of magnesium metabolism

2.81

1.29

1.0

1.1

7.52

7.38

—

Autoimmune hyperthyroidism

1.76

1.29

1.2

7.47

7.40

—

Event of undetermined intent

1.76

1.29

1.1

1.4

7.37

7.41

0.28

Functional dyspepsia

534

1.29

1.28

1.2

7.45

7.41

1.16

373

Nontoxic goitre/thyroid nodule

649

1.27

1.28

1.2

1.3

7.42

0.14

452

Other viral diseases, not elsewhere classified, including avohilmo

418

1.33

1.28

1.3

7.41

7.40

0.15

289

Triptan medication for migraine, min. 3 purchases

553

0.76

1.28

1.2

1.3

7.38

7.42

0.58

373

Conjunctivitis

137

1314

0.84

1.26

1.2

1.3

7.44

7.41

1.10

920

Other otitis externa (chronic)

130

1.62

1.26

1.2

1.4

7.43

7.41

0.33

Other enthesopathy of foot (+metatarsalgia)

170

1.53

1.25

1.3

7.48

7.42

0.59

113

Alcohol-induced acute pancreatitis

1.83

1.25

1.4

7.24

7.40

—

Metatarsalgia

162

1.55

1.25

1.3

7.49

7.42

0.66

107

Primary gonarthrosis, bilateral

144

1428

0.84

1.25

1.3

7.39

7.41

0.39

106

1008

Vitamin B12 deficiency anaemia

269

1.42

1.25

1.3

7.46

7.40

2.03

184

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

262

1793

1.14

1.25

1.3

7.41

7.40

0.02

182

1262

Other enthesopathies

607

1.27

1.25

1.5

1.2

7.41

7.40

0.10

423

Abnormal findings in secretions and smears from cervix uteri vagina vulva

433

0.73

1.25

1.2

7.49

7.43

1.49

294

Tuberculosis, wide

203

1.48

1.24

1.5

1.3

7.41

7.42

0.04

144

Alzheimer’s disease (Late onset), excluding more controls

390

0.73

1.24

1.1

1.3

7.40

7.41

0.07

262

Barrett oesophagus

123

1.63

1.24

1.2

1.3

7.42

7.41

0.10

Other systemic involvement of connective tissue (FG)

571

1.27

1.23

1.2

1.3

7.38

7.42

0.44

403

Polyp of the female genital tract

314

0.72

1.23

1.4

1.2

7.44

7.46

0.15

218

Haemangioma, any site

155

1.55

1.22

1.5

1.4

7.46

7.41

1.68

106

Tuberculosis, wide, including avohilmo

204

1.47

1.22

1.5

1.3

7.41

7.42

0.04

144

Adalimumab

108

1.67

1.22

1.2

1.4

7.46

7.38

—

Other disorders of bone

330

1.37

1.21

1.4

1.3

7.41

7.40

0.16

225

Spermatocele

264

0.60

1.21

1.6

1.3

7.37

7.41

0.25

183

Acute alcohol intoxication ICD-9

1.80

1.21

1.0

1.3

7.44

7.39

—

Varicose veins of other sites

116

1.64

1.21

1.3

1.4

7.49

7.40

1.36

Disorders of conjunctiva

167

1509

0.86

1.20

1.3

7.45

7.41

2.19

109

1062

Anxiety (asthma-related co-morbidities)

120

756

1.21

1.20

1.2

1.3

7.35

7.42

1.62

530

L02BB Anti-androgens

360

0.66

1.20

1.4

7.42

7.40

0.35

252

Maternal care related to the fetus and amniotic cavity and possible delivery problems

255

0.69

1.20

1.2

7.42

7.43

0.12

172

Vestibular neuronitis

213

0.56

1.19

1.2

1.4

7.48

7.41

—

151

Strabismus

495

1.29

1.19

1.3

7.40

0.03

336

Other joint disorders

235

1070

1.15

1.19

1.3

1.2

7.40

0.19

157

745

Benign neoplasm: Duodenum

1.89

1.18

1.0

1.3

7.55

7.37

—

Postprocedural disorders of nervous system

1.88

1.18

1.0

1.2

7.47

7.39

—

Psoriatic and enteropathic arthropathies

206

1.46

1.17

1.6

1.3

7.43

7.38

0.52

146

Appendectomy

152

1232

1.17

1.16

1.3

7.38

7.41

0.71

112

848

Rotator cuff syndrome

201

1201

1.15

1.16

1.2

1.3

7.41

7.40

0.09

141

839

Panhypopituitarism

2.06

1.15

1.4

7.44

7.36

—

Other and unspecified disorders of vitreous body

1110

0.82

1.15

1.2

1.3

7.41

0.06

787

Lifestyle-related condition

2.52

1.15

1.2

1.4

7.36

7.30

—

Abnormal findings on antenatal screening of mother

0.00

1.15

0.0

1.2

—

7.40

—

Gestational diabetes (for exclusion)

163

0.59

1.14

1.1

1.2

7.38

7.43

—

106

Psoriasis vulgaris

421

1.31

1.14

1.5

1.3

7.41

7.40

0.08

283

Acute nasopharyngitis (common cold)

165

1.50

1.13

1.3

7.42

7.39

0.24

124

Dementia

150

1200

0.85

1.13

1.2

1.3

7.41

0.01

113

854

Injuries to the shoulder and upper arm

265

1813

1.13

1.2

1.3

7.37

7.41

1.35

190

1274

Hyperosmolality and hypernatraemia

2.35

1.12

1.0

7.39

7.40

—

Early lumbar disc prolapse, operated

1.75

1.12

1.1

1.3

7.42

7.41

—

Intestinal adhesions without obstruction

208

1.45

1.12

1.2

1.3

7.45

7.40

0.94

141

Other diseases of anus and rectum

101

830

1.21

1.12

1.3

7.45

7.40

2.70

589

Pain in thoracic spine

267

1.39

1.12

1.2

1.3

7.39

7.41

0.19

184

Non-selective monoamine reuptake inhibitors

110

878

1.20

1.11

1.3

7.35

7.43

2.11

632

Infections with a predominantly sexual mode of transmission

352

1.33

1.11

1.1

1.3

7.39

7.40

0.14

230

Panic disorder

135

1.56

1.11

1.3

7.42

7.39

0.31

Coeliac disease

217

1.43

1.11

1.2

1.4

7.46

7.41

0.98

149

Severe visual impairment, monocular

2.40

1.09

1.0

1.3

7.51

7.40

—

Benign neoplasm: Spinal cord

2.39

1.09

1.2

1.5

7.30

7.34

—

Torticollis

2.39

1.09

2.0

1.1

7.47

7.43

—

Urticaria and erythema

664

1.24

1.09

1.2

1.3

7.44

7.41

0.69

454

Macular pucker

486

1.28

1.09

1.3

7.42

7.40

0.47

326

Residual foreign body in soft tissue

1.73

1.09

1.3

7.40

7.42

—

Diabetic neuropathy

371

1.32

1.07

1.1

1.3

7.43

7.41

0.50

258

Obesity, other/unspecified

576

1.25

1.07

1.2

1.3

7.36

7.40

0.83

392

Disorders of eyelid, lacrimal system and orbit

271

1770

1.12

1.07

1.2

1.3

7.42

7.40

0.82

185

1258

Benign paroxysmal vertigo

772

0.79

1.07

1.5

1.3

7.41

7.42

0.06

543

Chondropathies

261

1.38

1.07

1.4

7.41

7.40

0.13

178

Hypertrophic scar

1.76

1.06

1.0

1.3

7.39

—

Other benign neoplasms of connective and other soft tissue

194

1.45

1.06

1.3

1.4

7.46

7.40

1.47

132

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

1.65

1.06

1.4

1.3

7.35

7.44

0.82

Assault

161

1.49

1.06

1.1

1.3

7.41

7.38

0.17

112

Pruritus

236

1.40

1.06

1.2

1.3

7.39

7.41

0.13

163

Hypertrophic disorders of skin

1.71

1.05

1.0

1.4

7.39

—

Other and unspecified myopathies

237

1.40

1.04

1.4

1.3

7.33

7.41

0.80

165

Malignant neoplasm of lip, including Hilmo

2.29

1.03

1.2

1.4

7.29

7.37

—

Benign neoplasm: Oesophagus

2.29

1.03

1.4

7.50

7.33

—

Hypothyroidism, other/unspecified

254

1486

1.12

1.03

1.3

7.41

7.40

0.07

178

1036

Melanoma in situ

122

1.56

1.02

1.1

1.4

7.45

7.39

0.55

Abrasion of teeth

745

0.79

1.02

1.3

7.37

7.41

0.85

518

Procreative management

388

1.27

1.02

1.2

1.3

7.49

7.40

2.17

258

Other inflammatory liver diseases

122

1.56

1.02

1.4

1.3

7.44

7.41

0.38

Umbilical hernia

680

1.22

1.01

1.2

1.3

7.43

7.39

1.10

462

Other diseases of upper respiratory tract

345

1626

1.11

1.01

1.3

7.42

7.40

0.83

227

1167

Fissure and fistula of anal and rectal regions

519

1.25

1.00

1.4

1.3

7.42

7.40

0.30

354

Graves disease, strict definition

131

1.53

0.99

1.2

1.3

7.44

7.40

0.38

Wet age-related macular degeneration

614

1.23

0.98

1.3

7.42

0.03

422

Visual disturbances and blindness

157

1363

1.15

0.98

1.2

1.3

7.42

7.41

0.44

119

954

Cardiac murmurs and other cardiac sounds

114

1.56

0.98

1.3

7.41

7.38

0.42

Other intervertebral disc disorders

246

1307

1.12

0.98

1.3

7.42

7.40

0.49

169

912

Polyhydramnios

0.00

0.97

0.0

1.1

—

7.46

—

Open bite

0.00

0.97

0.0

1.2

—

7.39

—

Other inflammation of eyelid, including avohilmo

839

0.81

0.97

1.3

7.42

7.41

0.15

579

Other infestations, including avohilmo

1.95

0.97

1.3

7.36

7.37

—

Corneal ulcer

362

1.30

0.97

1.2

1.3

7.45

7.40

0.79

249

Hydrocephalus

211

0.61

0.96

1.1

1.3

7.43

7.41

—

140

Benign neoplasm: Stomach

241

1.37

0.96

1.3

1.4

7.47

7.41

1.78

164

Parkinson's disease, strict definition

480

0.75

0.96

1.5

1.3

7.37

7.41

0.78

328

Nail disorders

141

1.49

0.94

1.3

1.4

7.37

7.40

0.18

Headache

139

926

1.16

0.94

1.3

7.41

7.40

0.29

101

654

Other symptoms and signs involving the urinary system

268

1.35

0.94

1.5

1.3

7.37

7.40

0.35

191

Urolithiasis

987

0.83

0.93

1.5

1.3

7.39

0.10

688

Benign neoplasm: Transverse colon

312

1.32

0.93

1.2

1.3

7.39

7.40

0.06

218

Superficial injury of lower leg

498

1.25

0.92

1.3

7.41

7.40

0.17

338

Foreign body entering into or through eye or natural orifice

150

1.47

0.92

1.6

1.4

7.34

7.39

0.44

105

Other predominantly sexually transmitted diseases, not elsewhere classified

150

1.47

0.92

1.1

1.3

7.43

7.41

0.31

Benign lipomatous neoplasm of other sites/unspecified

220

0.63

0.91

1.1

1.3

7.39

7.41

—

153

Superficial injury of ankle and foot

159

1.45

0.91

1.4

7.37

7.40

0.23

115

Complications of other internal prosthetic devices, implants and grafts

1.60

0.90

1.3

7.46

7.40

—

Other symptoms and signs involving general sensations and perceptions

1.60

0.90

1.3

1.4

7.19

7.40

—

Parkinson's disease

508

0.77

0.90

1.5

1.3

7.37

7.41

0.82

345

Other aneurysm

143

1.47

0.89

1.4

1.3

7.45

7.39

0.77

104

Other abnormal uterine and vaginal bleeding

300

1.27

0.89

1.2

7.47

7.46

0.20

209

Haemangioma and lymphangioma, any site

168

1.43

0.89

1.5

1.4

7.46

7.41

1.73

112

262

1.34

0.89

1.4

7.35

7.40

0.37

188

Viral warts

160

1.44

0.88

1.3

1.4

7.49

7.40

0.92

107

Myeloproliferative diseases (CML excluded)

194

1.40

0.88

1.3

7.44

7.41

0.48

137

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

959

0.84

0.87

1.2

7.44

7.42

0.39

666

Traumatic subdural haemorrhage

444

1.24

0.87

1.3

7.43

7.40

0.40

296

Pure hyperglyceridaemia

1.87

0.87

1.6

1.2

7.26

7.39

—

Female infertility

223

0.73

0.87

1.1

1.2

7.36

7.44

0.88

152

Lumbar disc prolapse

184

1207

1.13

0.86

1.3

7.43

7.40

1.45

122

835

Contact with and exposure to communicable diseases

323

1.29

0.86

1.2

1.3

7.42

7.40

0.38

212

Female infertility, cervical, vaginal, other or unspecified origin

215

0.71

0.86

1.1

1.2

7.35

7.44

0.90

148

Respiratory tuberculosis, confirmed and not-confirmed

153

1.44

0.85

1.4

7.44

7.40

0.30

112

Respiratory tuberculosis

153

1.44

0.85

1.4

7.44

7.40

0.30

112

Use of levodopa decarboxylase inhibitor

470

0.76

0.85

1.4

1.3

7.38

7.41

0.48

319

Disorders of skin appendages

113

966

1.16

0.85

1.3

7.39

7.40

0.20

668

Fracture of skull and facial bones

477

1.24

0.85

1.2

1.3

7.36

7.39

0.35

324

Spondylopathies (FG)

221

1.36

0.85

1.5

1.3

7.46

7.39

0.79

155

Spondylosis

175

1210

1.13

0.85

1.3

7.38

7.41

0.82

132

845

Acute gastritis

170

1.41

0.85

1.5

1.3

7.43

0.01

121

Organic, including symptomatic, mental disorders

213

1341

1.12

0.84

1.2

1.3

7.40

0.10

161

950

Benign neoplasm: Skin of trunk

1.63

0.84

1.5

1.3

7.32

7.39

—

Tonsillectomy and adenotomy

521

0.81

0.84

1.1

1.3

7.38

7.40

0.25

350

Allergic conjunctivitis

990

0.84

1.2

7.44

7.42

0.32

686

Focal epilepsy, strict definition

478

1.24

0.84

1.2

1.3

7.44

7.41

0.62

317

Sciatica+with lumbago

145

1125

1.14

0.83

1.3

7.40

0.01

781

Retinal breaks without detachment

388

0.75

0.82

1.4

1.3

7.43

7.39

0.56

256

All anxiety disorders

120

805

1.16

0.82

1.2

7.35

7.41

1.22

557

Benign neoplasm of mouth and pharynx

240

1.34

0.82

1.3

1.4

7.45

7.40

0.79

165

Ingrowing nail

1.61

0.81

1.3

7.29

7.38

—

Arthrosis

212

1041

1.12

0.80

1.3

1.2

7.40

0.25

149

727

Atopic dermatitis, strict definition

333

0.73

0.80

1.6

1.3

7.34

7.41

0.61

231

Glaucoma-related operations

164

0.61

0.80

1.1

1.4

7.26

7.41

—

114

Noninflammatory disorders of female genital tract

325

0.80

1.3

1.2

7.45

0.03

227

Injuries to the elbow and forearm

186

1424

1.12

0.79

1.3

7.41

0.05

136

1002

Disorders of iron metabolism

0.00

0.79

0.0

1.1

—

7.37

—

Stomatitis and related lesions

383

1.25

0.79

1.2

1.3

7.43

7.41

0.39

256

Alcohol abuse, main dg

321

1.28

0.78

1.1

1.3

7.39

0.00

226

Procedures for purposes other than remedying health state

0.00

0.78

0.0

1.0

—

7.39

—

Autoimmune hepatitis, wide definition

1.63

0.78

1.1

1.2

7.48

7.41

—

Cystitis

212

1398

0.90

0.77

1.2

1.3

7.39

7.40

0.28

135

1009

Other obstetric trauma

0.00

0.77

0.0

1.3

—

7.42

—

Benign neoplasm of meninges

234

0.68

0.77

1.5

1.3

7.49

7.42

2.24

158

Benign neoplasm of ovary

269

1.30

0.77

1.1

1.2

7.42

0.01

176

Foreign body in alimentary tract

115

1.48

0.76

1.2

1.4

7.35

7.41

0.39

Delivery, wide proxy

347

0.81

0.76

1.2

7.41

7.45

0.52

243

Benign neoplasm: Brain, supratentorial

0.00

0.76

0.0

1.4

—

7.33

—

Glaucoma

204

1561

1.11

0.76

1.3

7.41

0.01

155

1107

Astigmatism

1.52

0.75

1.4

7.40

7.39

—

Early lumbar disc prolapse operation

1.54

0.75

1.1

1.4

7.42

7.38

—

Injuries to the ankle and foot

165

1256

1.12

0.74

1.2

1.3

7.40

7.41

0.06

107

873

Other disorders of Eustachian tube

1.64

0.73

1.3

1.2

7.44

7.36

—

Fenamates

275

0.77

0.73

1.5

1.4

7.36

7.42

0.66

199

Embolic stroke

150

1.40

0.73

1.3

7.33

7.42

0.58

105

Hypothyreosis and Thyroxine purchase for inclusion criteria

261

1561

1.09

0.73

1.3

7.41

7.40

0.14

183

1097

Fracture of forearm

143

1138

1.13

0.73

1.2

1.3

7.43

7.42

0.26

801

Nonorganic sleeping disorders

343

1.25

0.72

1.1

1.3

7.38

7.40

0.20

235

Sleep apnoea, including avohilmo

294

1632

1.09

0.72

1.4

1.3

7.40

7.41

0.17

199

1145

Primary hyperparathyroidism

237

1.31

0.72

1.3

7.42

0.05

151

Fall on same level involving ice and snow

160

1429

1.12

0.72

1.3

7.45

7.41

2.08

102

1011

Herpesviral [herpes simplex] infections

220

1.32

0.71

1.2

1.4

7.43

7.40

0.49

146

Dementia, including avohilmo

167

1270

0.90

0.71

1.2

1.3

7.40

7.41

0.08

126

901

Dermatitis and eczema

329

1798

1.08

0.71

1.3

7.41

7.40

0.30

235

1261

Gonarthrosis

199

1014

1.11

0.71

1.3

1.2

7.38

7.41

0.62

141

714

Other diseases of urinary system

298

1538

1.09

0.70

1.3

7.40

0.08

198

1099

Focal epilepsy, mode (most common among epilepsy diagnosis)

444

1.22

0.70

1.2

1.3

7.43

7.41

0.25

299

Otitis externa

490

1.21

0.70

1.2

1.3

7.41

7.40

0.12

330

Faecal incontinence

186

1.35

0.70

1.2

1.3

7.39

7.43

0.19

123

Other systemic involvement of connective tissue

647

1.18

0.69

1.2

1.3

7.38

7.42

0.49

452

Visual disturbances

138

1227

1.13

0.69

1.3

7.41

0.11

104

855

Gonarthrosis [arthrosis of knee](FG)

228

1194

1.10

0.68

1.3

1.2

7.38

7.40

0.66

163

841

Artrosis, including avohilmo

222

1334

0.91

0.68

1.2

1.3

7.40

7.41

0.31

145

939

Acute appendicitis, with complications

455

1.21

0.68

1.5

1.3

7.40

0.05

311

Benign neoplasm: Descending colon

187

1.34

0.68

1.6

1.3

7.42

7.40

0.18

131

Calculus of kidney and ureter

888

0.86

0.68

1.6

1.3

7.39

7.40

0.12

619

Benign leiomyoma with endometriosis

261

0.73

0.67

1.3

1.2

7.41

7.43

0.24

166

Missing teeth due to accident, extraction or parodontitis

201

1631

1.10

0.67

1.3

7.41

7.40

0.19

147

1145

Endometriosis

322

0.81

0.67

1.2

7.39

7.45

1.30

224

Atopic dermatitis, strict definition with reimbursement

370

0.78

0.67

1.5

1.3

7.36

7.40

0.28

254

Carcinoma in situ of skin

241

1.29

0.65

1.3

7.41

0.12

164

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.58

0.65

1.2

7.46

7.37

—

Other surgical follow-up care

1.59

0.65

1.3

1.2

7.41

—

Uterine polyps

303

0.81

0.65

1.4

1.2

7.44

7.45

0.14

211

Diplopia

313

1.25

0.64

1.3

1.4

7.39

7.40

0.23

214

Haemorrhage in early pregnancy

284

0.75

0.63

1.1

1.2

7.43

7.42

0.08

192

Scabies, including avohilmo

172

1.34

0.63

1.1

1.4

7.45

7.39

0.43

120

Neuromuscular dysfunction of bladder

225

1.29

0.63

1.2

1.3

7.43

7.39

0.56

158

Rheumatism, unspecified

225

1.29

0.63

1.3

1.2

7.43

7.42

0.05

155

Parkinson's disease, including avohilmo

524

0.82

0.62

1.4

1.3

7.37

7.41

0.78

356

Iridocyclitis

488

1.19

0.62

1.4

1.3

7.45

7.40

1.15

335

Myocardial infarction, unclassifiable

751

1.14

0.62

1.3

7.44

7.40

1.01

526

Delivery

392

0.85

0.61

1.4

1.2

7.43

7.44

0.18

273

Portal vein thrombosis

1.67

0.61

1.6

1.3

7.47

7.34

—

Pediculosis, acariasis and other infestations, including avohilmo

244

1.27

0.60

1.2

1.4

7.42

7.40

0.19

166

Acute laryngitis and tracheitis

103

1.43

0.60

1.0

1.3

7.43

7.37

—

Combined immunodeficiencies

0.00

0.60

0.0

1.3

—

7.34

—

Ectropion of eyelid

139

1.37

0.60

1.1

1.3

7.43

7.42

0.18

Hyperfunction of pituitary gland

1.57

0.60

1.3

7.38

7.34

—

Parkinson's disease, strict definition, excluding more controls

415

0.81

0.60

1.5

1.3

7.37

7.41

0.67

277

Schizotypal disorder

0.00

0.60

0.0

1.3

—

7.34

—

Viral warts, including avohilmo

371

1.21

0.60

1.3

7.46

7.39

1.38

244

Artificial joint re-operation

174

1.32

0.60

1.3

1.4

7.32

7.42

0.76

116

Injury of muscle and tendon at shoulder and upper arm level

1015

0.88

0.60

1.2

1.3

7.39

0.00

704

Adhesive middle ear disease

0.00

0.59

0.0

1.5

—

7.31

—

Gingivitis and periodontal diseases

311

1493

1.08

0.59

1.2

1.3

7.41

0.02

203

1068

L02BX Other hormone antagonists and related agents

220

0.73

0.59

1.6

1.4

7.32

7.39

—

156

Injuries to the wrist and hand

247

1770

0.92

0.58

1.3

7.38

7.41

0.74

168

1250

Chronic myeloproliferative disease

1.72

0.58

1.3

1.4

7.40

7.39

—

Anterior Iridocyclitis

437

1.19

0.57

1.4

1.3

7.45

7.40

1.24

296

Radiculopathy

419

1.19

0.57

1.1

1.3

7.40

7.41

0.06

291

Alzheimer’s disease (Atypical or mixed)

425

0.81

0.57

1.3

7.37

7.43

0.66

304

Other/unspecified synovitis and tenosynovitis

220

1.27

0.56

1.1

1.3

7.47

7.40

1.95

149

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

176

1.31

0.56

1.1

1.3

7.43

7.40

0.48

116

Injuries to the neck

448

1.18

0.55

1.4

1.3

7.40

0.06

304

Diabetes mellitus in pregnancy

132

0.72

0.55

1.1

1.2

7.36

7.44

—

Other and unspecified nail disorders

1.63

0.55

1.2

1.3

7.40

7.37

—

Type 1 diabetes, strict (exclude DM2)

1.50

0.55

1.1

1.2

7.48

7.41

—

Benign neoplasm: Skin of other and unspecified parts of face

257

1.25

0.55

1.3

1.4

7.41

0.02

181

Other and unspecified effects of external causes

458

1.18

0.55

1.3

7.40

0.04

309

Family history of certain disabilities and chronic diseases leading to disablement

1.58

0.54

1.0

1.3

7.51

7.40

—

Other diseases of gallbladder

1.42

0.54

1.4

1.3

7.42

7.41

—

Pollen allergy

140

1.34

0.54

1.2

1.3

7.45

7.39

—

Episodal and paroxysmal disorders

307

1454

1.07

0.54

1.3

7.41

7.40

0.25

223

999

Retinal detachment with retinal break

358

1.20

0.53

1.1

1.3

7.42

7.39

0.17

241

Benign neoplasm: Skin of eyelid, including canthus

383

0.81

0.53

1.3

7.42

7.41

0.18

260

Diseases of the ear and mastoid process

282

1515

0.93

0.53

1.2

1.3

7.39

7.41

0.44

192

1053

Diseases of pulp and periapical tissues, including avohilmo

311

1503

1.07

0.53

1.2

1.3

7.40

0.02

210

1080

Examination and encounter for administrative purposes

227

0.75

0.53

1.4

1.2

7.48

7.40

1.60

143

Single spontaneous delivery

392

0.86

0.53

1.4

1.2

7.43

7.44

0.38

273

Type 1 diabetes, definitions combined

1.48

0.52

1.1

1.2

7.48

7.41

—

Presence of other devices

747

0.87

0.52

1.3

7.44

7.41

1.00

515

Deforming dorsopathies

591

1.15

0.52

1.3

7.39

7.41

0.15

415

Spontaneous abortion

401

0.85

0.51

1.1

1.2

7.40

7.44

0.64

270

Subarachnoid haemorrhage

251

1.24

0.51

1.7

1.3

7.41

0.06

169

Mouth breathing

102

912

1.12

0.50

1.3

7.40

7.39

0.14

621

Myalgia

444

1.17

0.50

1.3

1.2

7.46

7.40

1.24

312

Carcinoma in situ, bladder

118

1.36

0.50

1.6

1.4

7.38

7.40

0.24

Bullous disorders

153

1.31

0.50

1.4

1.3

7.46

7.41

0.98

106

Benign neoplasm: Cerebral meninges

213

0.75

0.50

1.5

1.3

7.49

7.42

2.07

139

Other diseases of hard tissues of teeth

167

943

0.92

0.49

1.3

7.41

0.06

114

676

Alzheimer’s disease (Atypical or mixed), excluding more controls

300

0.82

0.49

1.3

7.37

7.42

0.61

195

Any dementia, excluding more controls

133

1004

0.91

0.49

1.2

1.3

7.41

0.00

715

Disorders of orbit

1.50

0.49

1.1

1.2

7.39

—

Other peripheral vascular diseases

145

1.31

0.48

1.2

1.3

7.42

7.40

0.07

101

Allergic rhinitis

405

0.83

0.48

1.2

1.3

7.39

7.40

0.06

275

Gonarthrosis,primary

265

1706

0.94

0.48

1.3

7.38

7.41

0.81

193

1200

Other fall from one level to another

483

1.16

0.48

1.4

1.3

7.37

7.39

0.40

328

Parkinson's disease, excluding more controls

427

0.84

0.48

1.5

1.3

7.37

7.40

0.54

287

Crushed, pushed or stepped on by crowd or human stampede

1.45

0.48

1.3

7.40

7.38

—

5-aminosalicylic acid

345

1.19

0.47

1.3

7.40

7.39

0.08

230

Glucagon-like peptide-1 (GLP-1) analogues

625

1.14

0.47

1.5

1.3

7.36

7.39

0.33

427

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

625

1.14

0.47

1.5

1.3

7.36

7.39

0.33

427

Persistent mood disorders

373

1.18

0.47

1.4

1.3

7.36

7.41

0.75

258

Pain associated with micturition

263

1.22

0.47

1.5

1.3

7.44

7.40

0.55

184

Trochanteric bursitis

299

0.80

0.46

1.1

1.2

7.42

0.04

210

Pregnancy, childbirth and the puerperium

310

0.86

0.46

1.2

7.42

7.45

0.35

219

Dermatophytosis, including avohilmo

175

1586

1.08

0.46

1.3

7.40

0.02

123

1107

Benign neoplasm: Colon, unspecified

778

1.12

0.45

1.5

1.3

7.41

0.03

532

Migraine with aura

309

0.81

0.45

1.2

1.3

7.43

7.40

0.39

198

Entropion and trichiasis of eyelid

276

0.80

0.45

1.2

1.3

7.34

7.42

0.32

187

Transport accidents

109

821

1.10

0.45

1.3

7.36

7.40

0.88

584

severe traumatic brain injury, does not include concussion

722

1.12

0.45

1.3

7.43

7.40

0.90

500

Special screening examination for other diseases and disorders

246

1.22

0.45

1.2

7.47

7.39

0.96

150

Sequelae of injuries of upper limb

165

1.27

0.45

1.7

1.5

7.33

7.39

0.46

115

Other and unspecified glaucoma

201

1.25

0.44

1.5

1.3

7.36

7.41

0.31

141

Periapical abscess

113

1027

1.10

0.44

1.1

1.3

7.37

7.41

0.78

706

Use of antiglaucoma preparations and miotics

238

1.22

0.44

1.2

1.3

7.38

7.42

0.42

163

Cervicalgia

459

0.85

0.44

1.4

1.3

7.45

7.41

0.68

323

Urticaria

488

1.15

0.43

1.3

7.46

7.40

0.97

333

Colonic or urogenital fistula

620

1.13

0.43

1.3

7.43

7.40

0.59

418

Burns and corrosions of external body surface, specified by site

184

1.25

0.43

1.2

1.4

7.45

7.39

0.89

131

Suppurative and unspecified otitis media

463

0.86

0.43

1.5

1.3

7.41

7.40

0.14

307

Any dementia

150

1124

0.92

0.43

1.2

1.3

7.41

0.04

107

799

Other hearing loss

109

960

1.10

0.43

1.4

1.3

7.41

0.01

668

Hyperprolactinaemia

1.61

0.43

1.4

7.40

7.34

—

Postpartum haemorrhage

153

0.75

0.43

1.1

1.2

7.42

—

103

Other extrapyramidal and movement disorders in other diseases

639

0.88

0.42

1.2

1.3

7.31

7.41

1.82

432

Necrosis of pulp, including avohilmo

107

1161

0.91

0.42

1.3

7.42

7.40

0.47

804

Chronic laryngitis and laryngotracheitis

331

1.18

0.42

1.2

1.3

7.40

0.03

231

Excessive attrition of teeth

112

1214

0.91

0.42

1.3

7.42

7.40

0.34

832

Pain and other conditions associated with female genital organs and menstrual cycle

201

0.79

0.42

1.1

1.2

7.39

7.44

0.58

137

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.57

0.42

1.2

1.3

7.43

7.36

—

Other diseases of blood and blood-forming organs

149

1.28

0.41

1.1

1.4

7.46

7.40

1.24

102

Other specified/unspecified necrotizing vasculopathies

1.52

0.41

1.6

1.3

7.33

7.37

—

Whooping cough, including avohilmo

0.00

0.41

0.0

1.0

—

7.41

—

LSIL lesion of the vagina

0.00

0.41

0.0

1.1

—

7.42

—

Dysplasia of cervi uteri

215

0.82

0.41

1.0

1.2

7.48

7.44

0.69

149

Pyoderma

1.47

0.40

1.4

1.1

7.40

7.37

—

Soft tissue disorders related to use, overuse and pressure

681

1.12

0.40

1.5

1.2

7.36

7.41

0.68

475

Retinal vascular disorders

361

1.16

0.40

1.4

1.3

7.41

0.02

243

Extrapyramidal and movement disorders

106

1160

0.91

0.40

1.3

7.35

7.41

1.85

818

Other orthopaedic follow-up care

1.37

0.40

1.2

7.20

7.43

—

Impingement syndrome of shoulder

559

1.13

0.39

1.2

7.40

0.10

387

Other intracranial haemorrhages

104

0.67

0.39

1.3

7.53

7.41

—

Lichen planus, including avohilmo

418

1.15

0.39

1.5

1.3

7.40

0.01

284

Stenosis and insufficiency of lacrimal passages

214

1.22

0.39

1.2

1.3

7.42

0.12

139

Idiopathic urticaria

0.00

0.39

0.0

1.2

—

7.36

—

Premature separation of placenta [abruptio placentae]

0.00

0.39

0.0

1.1

—

7.43

—

Mandibular retrognathia AND surgery (BSSO)

0.00

0.39

0.0

1.1

—

7.42

—

Cervicobrachial syndrome

421

0.85

0.39

1.3

1.2

7.45

7.41

0.58

289

Psoriatic arthropathies

196

1.23

0.39

1.5

1.3

7.43

7.38

0.44

140

Cysts of oral region, not elsewhere classified

115

1.31

0.38

1.2

1.4

7.47

7.39

—

Salpingitis and oophoritis

233

1.20

0.38

1.3

1.2

7.41

7.42

0.16

153

LSIL lesion of the cervix uteri

1.38

0.38

1.0

1.3

7.45

7.41

—

Injury of muscle and tendon at lower leg level

345

0.84

0.38

1.4

1.3

7.39

7.40

0.14

238

Leiomyoma of uterus

116

596

1.09

0.38

1.2

7.46

7.44

0.42

426

Hallux valgus (acquired)

566

0.90

0.38

1.3

1.2

7.40

7.42

0.19

410

Superficial injury of thorax

354

1.16

0.38

1.3

1.4

7.47

7.41

1.23

251

Complications predominantly related to the puerperium

258

0.81

0.38

1.2

7.52

7.41

1.18

174

Sequelae of injuries of head

1.35

0.38

1.1

1.3

7.44

7.40

—

Other hammer toe(s) (acquired)

401

0.86

0.37

1.5

1.3

7.45

7.42

0.85

294

Bipolar affective disorders

252

1.19

0.37

1.1

1.3

7.36

7.41

0.48

172

Alzheimer disease, excluding more controls

430

0.89

0.37

1.1

1.3

7.42

7.40

0.17

294

Spondylolisthesis/Spondylolysis

392

1.15

0.37

1.3

7.36

7.41

0.43

266

Special screening examination for infectious and parasitic diseases

220

0.83

0.37

1.2

7.37

7.36

0.01

142

Diseases of oral cavity, salivary glands and jaws

199

961

1.07

0.37

1.3

7.40

7.41

0.13

134

692

Puerperal sepsis

158

0.76

0.37

1.1

1.3

7.65

7.40

—

105

Restless leg syndrome

311

0.84

0.36

1.2

1.4

7.31

7.41

0.92

207

Other disorders of the genitourinary system

281

1.18

0.36

1.4

1.3

7.44

7.41

0.49

190

Diseases of external ear

908

1.09

0.35

1.2

1.3

7.38

7.40

0.28

626

Ankylosing spondylitis

162

1.24

0.35

1.6

1.3

7.46

7.40

0.41

111

Other abnormal findings in urine

1.40

0.35

1.3

1.4

7.44

7.37

—

Acute bronchiolitis

1.39

0.35

1.2

1.4

7.41

7.35

—

Adhesive capsulitis of shoulder

376

1.14

0.34

1.2

7.45

7.40

1.33

259

Inflammatory diseases of prostate (prostatitis)

447

0.87

0.34

1.9

1.3

7.36

7.39

0.22

318

Arthropathic psoriasis

218

1.19

0.34

1.5

1.3

7.43

7.41

0.22

147

Acute and subacute iridocyclitis

405

1.14

0.34

1.5

1.3

7.46

7.40

1.26

275

Vasomotor and allergic rhinitis

611

0.90

0.33

1.3

1.2

7.42

7.40

0.37

424

Disorders of refraction and accommodation

470

1.12

0.33

1.3

7.41

7.40

0.09

313

Dislocation, sprain and strain of joints and ligaments of knee

109

1064

0.93

0.33

1.2

1.3

7.39

7.40

0.14

733

Superficial injury of shoulder and upper arm

253

0.83

0.33

1.4

7.23

7.40

1.10

176

Follow-up examination after treatment for conditions other than malignant neoplasms

674

0.92

0.32

1.2

7.41

7.40

0.12

442

Impacted cerumen

317

0.85

0.32

1.3

1.4

7.39

7.40

0.14

219

Herpesviral [herpes simplex] infections, including avohilmo

417

1.13

0.31

1.2

1.3

7.41

7.40

0.12

283

Chalazion

230

0.83

0.31

1.2

1.4

7.43

7.40

—

156

Overexertion and strenuous or repetitive movements

174

1.21

0.31

1.3

1.4

7.37

7.40

0.20

120

Diseases of pulp and periapical tissues and dental caries

217

1054

1.06

0.31

1.2

1.3

7.40

7.41

0.31

136

774

Benign neoplasm: Skin of scalp and neck

1.32

0.31

1.3

1.4

7.46

7.39

—

Other and unspecified epidermal thickening

1.32

0.31

1.4

1.2

7.43

7.41

—

Meniscus derangement

158

985

1.06

0.30

1.2

7.41

0.02

117

692

Striking against or struck by other objects

665

1.10

0.30

1.2

1.3

7.40

7.39

0.09

450

Mixed conductive and sensorineural hearing loss

324

1.14

0.30

1.3

1.4

7.34

7.41

1.12

220

Carcinoma in situ of other and unspecified sites

129

1.24

0.30

1.6

1.4

7.38

7.40

0.24

Polyarthrosis

488

1.11

0.30

1.3

7.40

7.42

0.20

351

Other specified disorders of external ear

111

1.26

0.30

1.1

1.5

7.39

7.41

—

Respiratory tuberculosis, not confirmed, including avohilmo

111

1.26

0.30

1.3

1.4

7.42

7.39

—

Mental and behavioural disorders due to sedatives or hypnotics

1.31

0.30

1.1

1.2

7.32

7.41

—

Traumatic amputation of wrist and hand

102

1.28

0.30

1.2

1.5

7.39

7.41

—

Retinal vascular occlusion

353

1.13

0.30

1.4

1.3

7.43

7.41

0.27

238

Malignant neoplasm of bladder

166

1.21

0.29

1.8

1.4

7.43

7.42

0.15

114

Melanocytic naevi

630

0.90

0.29

1.3

7.41

7.40

0.06

430

Follow-up examination after treatment for malignant neoplasms

278

1.15

0.29

1.6

1.2

7.48

7.41

0.96

171

Endometriosis of ovary

235

0.84

0.29

1.1

1.2

7.38

7.45

0.55

157

Polypectomy (DHB20)

148

1.22

0.29

1.6

1.4

7.45

7.40

0.90

105

Other psoriatic arthropathies

185

1.19

0.29

1.6

1.4

7.44

7.40

0.38

127

Embedded and impacted teeth

176

0.83

0.28

1.1

1.4

7.38

0.03

124

Pregnancy with abortive outcome

101

566

0.93

0.28

1.2

7.40

7.44

1.35

394

Ankylosing spondylitis, ICD10

149

1.21

0.27

1.7

1.4

7.47

7.40

0.37

105

Abnormal involuntary movements

308

1.14

0.27

1.3

7.36

7.40

0.31

205

Diseases of male genital organs

155

827

0.94

0.27

1.4

1.3

7.38

0.03

112

568

Chronic rhinitis, nasopharyngitis and pharyngitis

642

1.09

0.27

1.3

7.42

7.39

0.62

447

Ptosis of eyelid

299

1.14

0.27

1.2

1.3

7.47

7.40

1.31

197

Other disorders of penis

279

0.86

0.27

1.9

1.3

7.49

7.40

1.11

188

Disorders of lacrimal system

116

1069

1.07

0.27

1.3

7.44

7.42

1.09

745

Excessive earwax

179

1706

0.95

0.27

1.3

7.42

7.40

0.38

116

1214

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

443

0.90

0.26

1.3

1.2

7.45

7.44

0.29

297

Dental caries, including avohilmo

241

1179

1.05

0.26

1.3

7.42

7.41

0.28

154

862

Psoriatic arthropathies, ICD10

187

1.18

0.26

1.6

1.4

7.44

7.40

0.38

127

Other osteochondropathies

104

1.25

0.26

1.7

1.4

7.38

—

Primary open-angle glaucoma

103

1058

0.94

0.26

1.4

1.3

7.37

7.41

1.12

737

Other and unspecified urticaria

310

1.13

0.25

1.5

1.4

7.46

7.41

0.68

206

Persistent delusional disorders

149

0.80

0.25

1.2

1.4

7.40

7.41

—

108

Ménière disease

235

0.85

0.25

1.5

1.4

7.40

0.06

162

Follicular cysts of skin and subcutaneous tissue

414

0.89

0.25

1.2

1.3

7.35

7.40

0.65

283

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

553

0.91

0.25

1.2

1.3

7.40

0.00

380

Enthesopathies of lower limb, excluding foot

454

1.10

0.25

1.3

7.45

7.41

0.69

315

Conjunctivitis (acute, non atopic)

538

1.09

0.25

1.3

7.46

7.40

1.97

358

Other keratitis

198

1.16

0.24

1.2

1.4

7.33

7.40

0.56

134

Carpal tunnel syndrome

160

1317

1.05

0.24

1.3

7.40

7.41

0.17

118

907

Obstructed labour due to maternal pelvic abnormality

191

0.84

0.24

1.3

7.42

0.03

128

Fracture at wrist and hand level

722

1.08

0.24

1.3

7.37

7.40

0.38

498

Crohn disease

208

1.15

0.24

1.4

7.41

0.06

137

Presbyopia

115

1.22

0.23

1.4

7.43

7.37

—

Artificial joint operation, meniscal resection

284

1750

1.04

0.23

1.3

7.39

7.41

0.67

214

1223

Other superficial mycoses, including avohilmo

147

0.82

0.23

1.1

1.4

7.33

7.39

—

100

Other and unspecified psoriasis

143

1.19

0.23

1.4

7.45

7.41

0.47

101

Nontraumatic intracranial haemmorrhage

630

1.08

0.23

1.5

1.3

7.42

7.40

0.28

435

HSIL lesion of the cervix uteri, vagina or vulva

162

1.17

0.22

1.1

1.2

7.47

7.43

0.63

102

Other noninflammatory disorders of uterus, except cervix

295

0.90

0.22

1.1

1.2

7.39

7.46

1.22

209

Rosacea

238

1.14

0.22

1.3

1.4

7.41

0.04

159

Infections with a predominantly sexual mode of transmission, including avohilmo

436

1.09

0.22

1.1

1.3

7.40

0.01

288

Xerosis cutis

1.22

0.22

1.4

1.1

7.46

7.36

—

Intracerebral haemorrhage

391

1.10

0.21

1.2

1.3

7.41

0.05

270

Other arthrosis

150

957

1.05

0.21

1.4

1.2

7.40

7.41

0.16

109

671

Glaucoma suspect

112

1059

1.06

0.21

1.3

7.40

7.41

0.23

738

Typhoid and paratyphoid fevers

0.00

0.21

0.0

1.1

—

7.41

—

Congenital malformations of anterior segment of eye

0.00

0.21

0.0

1.5

—

7.45

—

Cervical root disorders

0.00

0.21

0.0

1.5

—

7.37

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

201

1.15

0.21

1.2

1.3

7.45

7.40

0.31

140

Occlusion and stenosis of arteries, not leading to stroke

1.16

0.21

1.4

1.2

7.55

7.42

—

Superficial injuries involving multiple body regions

1.16

0.21

1.4

1.3

7.30

7.36

—

Other and unspecified mononeuropathies of upper limb

1.16

0.21

1.0

1.3

7.44

7.37

—

Flat foot [pes planus] (acquired)

173

1.16

0.20

1.2

1.3

7.34

7.39

—

122

Disorders of breast

678

0.93

0.20

1.2

7.42

7.44

0.33

475

Hallux rigidus

335

0.90

0.20

1.3

7.38

7.40

0.25

242

Specific development disorders of scholastic skills

0.00

0.20

0.0

1.2

—

7.25

—

IBD patients in KELA-register

408

0.91

0.20

1.3

7.39

0.04

272

Other disorders of eyelid

147

1324

1.05

0.20

1.2

1.3

7.42

7.41

0.24

943

Hydrocele

422

1.09

0.20

1.3

7.38

7.40

0.27

287

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

1.23

0.20

1.3

7.45

7.39

—

Cervical disc disorders

927

1.06

0.20

1.3

1.2

7.41

0.01

641

Other shoulder lesions

155

1.16

0.19

1.3

7.44

7.42

0.27

101

Complications of genitourinary prosthetic devices, implants and grafts

1.20

0.19

1.5

1.3

7.39

7.36

—

Internal derangement of knee

870

1.06

0.19

1.3

1.2

7.40

0.02

605

Pedal cyclist injured in transport accident

427

0.91

0.19

1.3

7.32

7.40

0.87

285

Anxiety disorders, excluding more controls

192

1179

1.04

0.19

1.2

1.3

7.39

7.42

1.11

129

836

Inflammatory bowel disease, strict (require KELA)

406

0.91

0.19

1.3

7.39

0.01

270

Caries of dentine, including avohilmo

248

1225

1.03

0.19

1.3

7.41

0.14

160

890

Lichen ruber planus, wide definition including periferal and oral lichen planus

482

1.08

0.18

1.5

1.3

7.40

7.41

0.07

331

Hypothyroidism, strict autoimmune, 3 medication purchases required

219

1420

1.04

0.18

1.3

7.41

0.01

155

1003

Respiratory tuberculosis, not confirmed

109

1.19

0.18

1.3

1.4

7.41

7.39

—

Injury of muscle and tendon at hip and thigh level

196

0.87

0.18

1.5

1.4

7.41

7.40

—

133

Depression or dysthymia

192

1009

1.04

0.18

1.3

7.38

7.41

0.94

130

719

Nummular dermatitis

213

1.13

0.18

1.4

1.3

7.39

7.40

0.05

150

Localized swelling, mass and lump of skin and subcutaneous tissue

764

1.06

0.18

1.2

1.3

7.41

0.03

522

Postpartum hemorraghe, all women as controls

160

0.85

0.18

1.1

1.2

7.42

—

104

Superficial injury of forearm

164

0.85

0.18

1.3

1.4

7.39

7.41

0.06

112

Benign neoplasm of middle ear and respiratory system

185

1.14

0.18

1.1

1.4

7.44

7.39

0.76

135

Infective bursitis

1.17

0.18

1.1

1.3

7.44

7.40

—

Mood disorders

248

1635

0.97

0.17

1.2

1.3

7.36

7.41

2.56

167

1162

Fall on and from ladder

195

0.87

0.17

1.2

1.4

7.36

7.40

0.20

139

Irregular menses

404

0.93

0.17

1.3

1.2

7.44

7.43

0.11

277

Subjective visual disturbances

543

1.07

0.17

1.3

7.43

7.41

0.43

364

Disorders of tooth development and eruption

245

1.10

0.16

1.4

1.3

7.40

7.41

0.15

169

Ganglion

350

0.91

0.16

1.3

1.2

7.44

7.40

0.68

240

Injuries involving multiple body regions

1.14

0.16

1.3

7.34

7.36

—

Car occupant injured in other and unspecified transport accidents

321

1.09

0.16

1.4

1.3

7.39

7.40

0.19

223

Selective serotonin reuptake inhibitors

266

1422

0.97

0.16

1.2

1.3

7.37

7.41

1.63

179

1024

Traumatic subarachnoid haemorrhage

1.20

0.16

1.1

1.4

7.43

7.41

—

Sudden idiopathic hearing loss

256

0.90

0.16

1.2

1.4

7.41

7.40

0.17

177

Superficial injury of wrist and hand

339

0.91

0.16

1.3

7.36

7.39

0.17

235

Injury of muscle and tendon at wrist and hand level

287

0.91

0.15

1.3

1.4

7.45

7.40

1.04

195

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

187

1.12

0.15

1.6

1.2

7.39

7.42

0.31

121

Coxarthrosis, primary

205

1649

1.03

0.15

1.4

1.3

7.42

7.40

0.67

159

1162

Other disorders of patella

266

0.90

0.15

1.2

1.3

7.47

7.39

0.85

190

Other female pelvic inflammatory diseases

216

1.11

0.15

1.1

1.2

7.38

7.42

0.34

137

Deviated nasal septum

847

1.05

0.15

1.3

7.38

7.39

0.12

594

Open wound of wrist and hand

1000

0.96

0.15

1.3

7.36

7.40

0.86

690

Other degenerative diseases of the nervous system

618

1.05

0.15

1.1

1.3

7.39

0.04

419

Propionic acid derivatives

470

0.95

0.15

1.3

1.4

7.40

7.41

0.23

334

Adverse effects, not elsewhere classified

313

1.09

0.15

1.3

7.42

7.40

0.24

206

Other specified/unspecified hearing loss

244

0.90

0.14

1.5

1.4

7.37

7.41

0.27

165

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

676

0.95

0.14

1.2

1.3

7.35

7.40

0.70

460

Polyuria

686

0.95

0.14

1.4

1.3

7.40

7.41

0.06

474

Primary coxarthrosis, bilateral

930

1.04

0.14

1.3

7.40

7.41

0.13

639

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

305

0.92

0.13

1.3

1.4

7.40

0.01

204

Hyperplasia of prostate

142

772

1.04

0.13

1.4

1.3

7.40

7.38

0.57

105

535

Ovarian cyst

322

0.94

0.13

1.4

1.2

7.41

7.45

0.47

224

Medical abortion

107

556

1.04

0.13

1.1

1.2

7.42

7.45

0.59

385

Other benign neoplasms of skin

104

1000

1.04

0.13

1.3

7.41

0.07

694

Retinal detachments and breaks

109

1050

1.04

0.13

1.3

7.42

7.40

0.39

746

Pregnancy hypertension

382

0.94

0.13

1.3

1.2

7.45

7.43

0.61

258

Redundant prepuce, phimosis and paraphimosis

551

1.05

0.12

1.4

1.3

7.40

7.39

0.09

381

HSIL lesion of the cervix uteri

123

1.14

0.12

1.1

1.2

7.51

7.42

—

Oxicams

463

0.96

0.12

1.3

1.4

7.37

7.41

1.05

332

Haemorrhoids and perianal venous thrombosis

927

1.04

0.12

1.3

7.37

7.40

0.54

649

Benign neoplasm: Caecum

307

1.08

0.12

1.3

1.4

7.39

7.40

0.06

207

Other inflammation of eyelid

307

1.08

0.12

1.2

1.3

7.38

7.41

0.23

202

Progressive vascular leukoencephalopathy

133

1.13

0.12

1.0

1.2

7.48

7.42

—

Gestational [pregnancy-induced] hypertension

230

0.91

0.12

1.1

1.2

7.44

7.42

0.42

150

Use of pramipexole

569

0.95

0.12

1.2

1.3

7.40

7.41

0.14

392

Other and unspecified vascular occlusions

278

1.08

0.12

1.5

1.3

7.40

0.01

184

Inflammatory bowel disease

640

1.05

0.11

1.3

7.41

7.40

0.20

428

Benign mammary dysplasia

230

0.91

0.11

1.2

7.39

7.42

0.26

153

Other specific joint derangements/joint disorders

166

1006

1.03

0.11

1.4

1.2

7.40

0.12

113

698

Mood [affective] disorders

249

1628

0.98

0.11

1.2

1.3

7.36

7.41

2.54

168

1156

Lesion of ulnar nerve

318

1.07

0.11

1.2

1.3

7.40

0.02

210

Conductive hearing loss, unspecified

157

0.89

0.11

1.3

1.5

7.42

—

105

Speech disturbances, not elsewhere classified

250

1.08

0.11

1.3

7.39

7.41

0.16

172

Blepharochalasis

819

1.04

0.10

1.2

1.3

7.39

7.42

0.44

560

Other peripheral vertigo

239

0.92

0.10

1.4

1.3

7.31

7.41

2.14

166

Cervicocranial syndrome

202

1.09

0.10

1.5

1.3

7.41

0.01

131

Carcinoma in situ of breast, intraductal

144

1.11

0.10

1.3

7.55

7.42

—

Inflammatory diseases of female pelvic organs

655

1.03

0.10

1.3

1.2

7.41

7.44

0.82

453

Lateral epicondylitis

222

1.08

0.10

1.6

1.3

7.41

7.40

0.02

151

Pre-eclampsia or eclampsia

228

0.92

0.10

1.5

1.2

7.45

7.42

0.73

151

Epiphora

1.09

0.09

1.0

1.2

7.44

7.39

—

Atrophic disorders of skin

281

1.07

0.09

1.5

1.3

7.46

7.42

0.37

186

Neurotic, stress-related and somatoform disorders

199

1341

1.02

0.09

1.2

1.3

7.38

7.41

1.03

132

937

Myopia

145

0.90

0.09

1.2

1.4

7.37

7.40

—

100

Postpartum hemorraghe, parous women as controls

130

0.90

0.09

1.1

1.2

7.41

7.42

—

All dysplastic lesions of the vulva

1.04

0.09

1.0

1.2

7.41

7.40

—

Acetic acid derivatives and related substances

470

1.03

0.09

1.4

7.38

7.41

0.73

334

Inguinal hernia, bilateral

350

1.06

0.09

1.5

1.3

7.38

7.40

0.20

245

Acute appendicitis

163

1479

1.02

0.08

1.3

7.37

7.40

0.93

121

1025

Adenomyosis (Endometriosis of uterus)

226

0.93

0.08

1.5

1.2

7.35

7.44

1.28

157

Benign neoplasm of male genital organs

1.03

0.08

1.0

1.4

7.39

—

Retinoschisis and retinal cysts

0.81

0.08

1.2

1.4

7.43

7.36

—

Other disorders of conjunctiva

379

0.95

0.08

1.5

1.3

7.47

7.40

2.93

253

Orchitis and epididymitis

287

0.94

0.08

1.4

1.3

7.39

7.40

0.14

200

Mood disorders, excluding more controls

240

1386

1.02

0.08

1.2

1.3

7.36

7.41

2.38

164

987

Benign neoplasm: Choroid

156

1.09

0.08

1.2

1.3

7.44

7.41

0.36

104

Exposure to other specified factors

196

1651

1.02

0.08

1.2

1.3

7.40

0.00

125

1162

Disorders of synovium and tendon

124

1076

0.98

0.07

1.4

1.2

7.44

7.40

2.38

749

Lichen planus

303

1.06

0.07

1.5

1.3

7.40

0.04

198

Coxibs

470

0.97

0.07

1.4

7.40

7.41

0.18

334

Acute appendicitis, no complications

108

1100

0.98

0.07

1.2

1.3

7.36

7.40

1.04

759

Melanocytic naevi of lower limb, including hip

0.80

0.07

1.0

1.2

—

7.38

—

Other congenital malformations of the digestive system, including avohilmo

1.09

0.07

1.1

1.2

7.43

7.37

—

Obstructed labour due to malposition and malpresentation of fetus

142

0.91

0.07

1.2

7.44

—

Sicca syndrome [Sjögren]

157

1.08

0.07

1.2

1.3

7.42

7.41

—

Pedal cyclist injured in other and unspecified transport accidents

206

1.07

0.07

1.3

1.4

7.40

7.41

0.11

144

Glucosamine medication

152

1190

1.02

0.07

1.3

7.44

7.42

1.00

108

840

Pain in joint

141

883

0.98

0.06

1.4

1.2

7.39

7.40

0.22

611

All dysplastic lesions of the cervix uteri

203

1.07

0.06

1.0

1.2

7.48

7.42

1.19

129

Peritonsillar abscess

356

0.95

0.06

1.1

1.2

7.49

7.39

2.30

245

Other specified/unspecified soft tissue disorders

1.11

0.06

1.3

1.2

7.37

7.42

—

Undefined dementia

403

0.96

0.06

1.2

1.3

7.44

7.42

0.19

285

Ulcerative colitis, NAS

246

1.06

0.06

1.3

7.45

7.40

0.56

168

Pre-eclampsia or poor fetal growth

263

0.95

0.06

1.5

1.2

7.42

7.41

0.14

169

Nonsuppurative otitis media, including avohilmo

417

1.04

0.06

1.3

7.39

7.40

0.09

282

Other disorders of the musculoskeletal system and connective tissue

345

1.04

0.06

1.1

1.4

7.39

7.40

0.07

235

Other disorders of prostate

121

0.91

0.06

1.4

1.3

7.47

7.41

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

527

0.97

0.06

1.2

1.3

7.40

0.05

365

Diseases of middle ear and mastoid

111

924

0.98

0.05

1.4

1.3

7.41

7.40

0.19

613

Colon adenocarcinoma, helper endpoint

405

1.04

0.05

1.2

1.3

7.40

7.42

0.15

277

Benign neoplasm of eye and adnexa

257

1.05

0.05

1.2

1.4

7.43

7.41

0.41

169

Other diseases of lip and oral mucosa

929

0.98

0.05

1.3

7.37

7.41

0.75

644

Symptoms and signs involving speech and voice

852

1.02

0.05

1.3

7.42

7.41

0.05

591

FESS (DNB20)

232

0.95

0.05

1.6

1.4

7.42

7.40

0.35

159

Other disorders of breast

181

0.94

0.05

1.1

1.2

7.43

7.42

—

117

Oter anti-inflammatory and antirheumatic agents, non-steroids

457

1.02

0.04

1.4

7.39

7.41

0.35

329

Acute suppurative otitis media

268

1.04

0.04

1.5

1.3

7.41

7.40

0.08

177

Somatoform disorder

268

1.04

0.04

1.1

1.4

7.41

0.00

179

Inguinal or femoral hernia, bilateral

357

1.04

0.04

1.5

1.3

7.38

7.40

0.21

250

Ulcerative colitis

496

1.03

0.04

1.3

7.41

7.40

0.15

330

Other congenital malformations, including avohilmo

160

0.94

0.04

1.3

1.4

7.47

7.40

—

109

Vascular dementia

359

0.97

0.04

1.2

1.3

7.42

0.01

252

Other disorders of eye and adnexa

249

1.04

0.04

1.1

1.4

7.42

7.41

0.08

165

Disturbances of skin sensation

493

0.97

0.04

1.2

1.3

7.34

7.41

1.16

331

Menorrhagia

321

1.02

0.04

1.3

1.2

7.43

7.45

0.36

225

LSIL lesion of the cervix uteri, vagina or vulva

121

1.07

0.03

1.0

1.2

7.45

7.43

—

Personal history of malignant neoplasm

129

0.93

0.03

1.5

1.3

7.44

7.39

—

Monoamine oxidase A inhibitors

240

1.04

0.03

1.4

1.3

7.33

7.42

0.49

170

Nasal polyp

518

1.02

0.03

1.3

7.37

7.39

0.18

362

Disorders of vitreous body and globe

148

1384

1.01

0.03

1.2

1.3

7.40

7.41

0.08

987

D07AA Corticosteroids, weak (group I)

219

0.96

0.03

1.2

1.4

7.39

7.40

0.10

154

Dislocation, sprain and strain of joints and ligaments at neck level

211

1.04

0.03

1.5

1.4

7.40

0.00

146

Contact with machinery

281

1.03

0.02

1.5

1.3

7.36

7.39

0.23

196

Irritable bowel syndrome

500

0.98

0.02

1.3

7.45

7.41

1.30

350

Glaucoma, exfoliation

329

0.97

0.02

1.3

7.37

7.43

0.64

224

Plantar fascial fibromatosis

172

1.05

0.02

1.3

7.39

7.41

0.17

113

Thyroiditis, ILD-related definition

188

0.96

0.02

1.3

7.40

7.42

0.32

123

Polymyalgia rheumatica

389

0.98

0.02

1.1

1.3

7.37

7.42

0.45

265

Acute pharyngitis

166

0.95

0.02

1.5

1.3

7.29

7.39

—

120

Anxiety disorders

200

1362

1.01

0.02

1.2

1.3

7.38

7.42

1.05

133

956

Sleep disorders (combined)

313

1626

1.00

0.02

1.3

7.41

0.02

214

1156

Other disorders of lacrimal gland

860

1.01

0.02

1.3

7.45

7.42

1.50

587

Primary open-angle glaucoma, strict

868

1.01

0.01

1.4

1.3

7.39

7.41

0.64

606

Otalgia

137

0.95

0.01

1.3

1.4

7.25

7.42

—

Diseases of appendix

173

1553

1.00

0.01

1.3

7.37

7.40

1.28

128

1077

Depression

227

1511

1.00

0.01

1.2

1.3

7.36

7.42

2.36

150

1067

Systemic atrophies primarily affecting the central nervous system

104

1.06

0.01

1.4

7.34

7.39

0.23

Ectopic pregnancy

184

1.03

0.00

1.3

1.2

7.46

7.43

0.54

122

Unspecified lump in breast

226

0.97

0.00

1.2

7.42

7.43

0.10

149

Seborrhoeic dermatitis

236

0.97

0.00

1.2

1.3

7.40

7.39

0.08

167

Ethmoidectomy

246

0.98

0.00

1.7

1.4

7.43

7.40

0.57

167

Memory loss

264

1.02

0.00

1.1

1.4

7.46

7.41

1.26

182

Effects of foreign body entering through natural orifice

536

0.99

0.00

1.3

7.34

7.40

1.28

368

Voice disturbances

616

0.99

0.00

1.4

1.3

7.43

7.41

0.39

413

Coxarthrosis, primary, with hip surgery

157

1461

1.00

0.00

1.4

1.3

7.41

7.40

0.10

122

1024

Appendicitis, broad definition

172

1540

1.00

0.00

1.3

7.37

7.40

1.04

127

1067

Hypertrophy of breast in women and men

291

1.00

0.00

1.1

1.3

7.43

7.42

0.22

198

Nonsuppurative otitis media

282

0.98

0.00

1.3

7.38

7.39

0.16

194

Generalized anxiety disorder

152

0.99

0.00

1.1

1.3

7.33

7.40

—

101

Disorders of vitreous body

142

1350

1.00

0.00

1.2

1.3

7.40

7.41

0.14

968

Seborrhoeic keratosis

684

0.99

0.00

1.3

7.41

0.10

471

Unspecified dementia

379

0.99

0.00

1.2

1.3

7.44

7.42

0.26

275

Allergic contact dermatitis

208

1.01

0.00

1.1

1.3

7.45

7.41

1.04

143

Aneurysms, operations, SAH

409

1.00

0.00

1.5

1.3

7.42

7.40

0.22

273

All dysplastic lesions of the cervix uteri, vagina or vulva

262

1.00

0.00

1.0

1.2

7.46

7.43

0.66

167

Other disorders of cornea

215

0.98

0.00

1.1

1.4

7.46

7.41

1.10

143

Trigger finger

285

1.02

0.00

1.7

1.2

7.43

7.40

0.56

196

Other disorders of bladder

375

0.99

0.00

1.5

1.3

7.44

7.39

1.68

265

Excessive, frequent and irregular menstruation

325

1.00

0.00

1.3

1.2

7.43

7.45

0.28

227

Anti-inflammatory and antirheumatic products, non-steroids

470

1.00

0.00

1.4

7.38

7.41

0.79

334

Benign neoplasm of breast

184

0.98

0.00

1.1

1.2

7.51

7.42

1.69

117

Achilles tendinitis

217

1.01

0.00

1.2

1.3

7.40

7.41

0.04

147

Preterm labour and delivery

275

1.02

0.00

1.1

1.2

7.37

7.44

0.69

190

Endometriosis ASRM stages 3,4

298

1.01

0.00

1.1

1.2

7.41

7.43

0.12

188

Other and unspecified nerve root and plexus disorders, also in other diseases

432

1.00

0.00

1.4

1.3

7.40

7.41

0.03

279

Scoliosis

113

0.97

0.00

1.1

1.3

7.53

7.42

—

Other and/or unspecified nontoxic goitre

167

1.02

0.00

1.3

7.39

7.41

—

113

Other sleep disorders

261

1.00

0.00

1.1

1.3

7.33

7.39

0.36

172

Livedoid vasculitis

0.00

0.0

1.0

—

7.50

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

2.0

—

7.37

—

Choroidal haemorrhage and rupture

0.00

0.0

1.1

—

7.24

—

Fourth [trochlear] nerve palsy

0.98

0.00

1.0

1.3

7.53

7.39

—

Lumbosacral plexus disorders

0.00

-0.00

0.0

1.2

—

7.35

—

Postpolio syndrome

0.00

-0.00

0.0

1.2

—

7.32

—

Cerebral oedema

0.00

-0.00

0.0

1.0

—

7.49

—

Corneal pigmentations and deposits

0.00

-0.00

0.0

1.2

—

7.35

—

Apocrine sweat disorders, other sweat gland disorders

0.00

-0.00

0.0

1.4

—

7.46

—

Femoral hernia, bilateral

0.00

-0.00

0.0

1.0

—

7.45

—

Chronic thyroiditis

0.00

-0.00

0.0

1.4

—

7.45

—

Other sudden death, cause unknown

0.00

-0.00

0.0

1.2

—

7.35

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

-0.00

0.0

1.2

—

7.21

—

Benign neoplasm: Ciliary body

0.00

-0.00

0.0

1.2

—

7.34

—

Benign neoplasm: other/unspecified salivary gland

0.85

-0.00

1.0

1.2

7.46

7.35

—

Other congenital malformations of the digestive system

0.96

-0.00

1.0

1.2

7.51

7.35

—

Febrile neutrophilic dermatosis [Sweet]

0.00

-0.00

0.0

1.2

—

7.34

—

Benign neoplasm: Skin of lower limb, including hip

0.98

-0.00

2.0

1.2

7.39

7.40

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.2

—

7.38

—

Other degenerative disorders of eyelid and periocular area

0.00

-0.00

0.0

1.9

—

7.28

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.2

—

7.33

—

Use of riluzole

0.00

-0.00

0.0

1.2

—

7.37

—

Oral leukoplakia, including avohilmo

0.93

-0.00

1.2

1.3

7.53

7.40

—

Oesophagitis, drug-induced

0.00

-0.00

0.0

1.2

—

7.34

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.2

—

7.34

—

Other hyperalimentation

0.00

-0.00

0.0

1.3

—

7.47

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

pH of Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS